East Tennessee State University

Digital Commons @ East Tennessee State University
Undergraduate Honors Theses

Student Works

5-2013

Recombination and Screening of Putative
Grapefruit Glucosyltransferase 4 Expressed in
Pichia pastoris.
Peri Loftis
East Tennessee State University

Follow this and additional works at: https://dc.etsu.edu/honors
Part of the Biology Commons
Recommended Citation
Loftis, Peri, "Recombination and Screening of Putative Grapefruit Glucosyltransferase 4 Expressed in Pichia pastoris." (2013).
Undergraduate Honors Theses. Paper 94. https://dc.etsu.edu/honors/94

This Honors Thesis - Withheld is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State University.
It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of Digital Commons @ East Tennessee State
University. For more information, please contact digilib@etsu.edu.

Recombination and Screening of Putative Grapefruit Glucosyltransferase 4
Expressed in Pichia pastoris

Thesis submitted in partial fulfillment of Honors

By

Peri Loftis
The Honors College
University Honors Scholars Program
East Tennessee State University

April 19, 2013

______________________________
Dr. Cecilia McIntosh, Faculty Mentor
______________________________
Dr. Andromeda Nauli, Faculty Reader
______________________________
Dr. Aruna Kilaru, Faculty Reader

1

CONTENTS

PAGE
ABSTRACT……………………………………………………………………........

3

ACKNOWLEDGEMENTS…………………………………………………………

4

CHAPTERS:
1. INTRODUCTION………………………………………………………

5

2. MATERIALS AND METHODS……………………………………….. 16
3. RESULTS AND DISCUSSION………………………………………... 48
4. SUMMARY AND FUTURE WORK…………………………………… 78
5. REFERENCES………………………………………………………….. 79
6. APPENDICES…………………………………………………………... 88

2

ABSTRACT

Flavonoids are a group of plant secondary metabolites that are vital to the cell systems of
plants. The intake of these chemicals is advantageous to animals for their antioxidant properties
that affect the function of immune and inflammatory cells. The bitter taste of grapefruit (Citrus
paradisi) and other citrus species is caused by the accumulation of glycosylated flavonoids.
Glucosyltransferases (GTs) are enzymes that add glucose moieties to a carbon or hydroxyl group
of natural products. The function of a putative secondary product GT clone was tested. In
previous research, putative GT 4 was cloned into a pCD1 modified pET expression system,
heterologously expressed in E.coli, and screened for activity with a few substrates; little GT
activity was found. Issues of protein localized to inclusion bodies in bacteria were addressed.
PGT 4 is being heterologously expressed in yeast (Pichia pastoris) to allow for protein
production and analysis. PGT 4 was screened for GT activity with different flavonoid subclass
representatives and simple phenolics.
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INTRODUCTION

I.

Plant Metabolism
The complex system of plant metabolism is a popular subject of academic and industrial

research. The intricate pathways and products of plants have been investigated for reasons of
pure academic knowledge to applied research in genetic engineering with economic implications
(Harborne and Simmonds, 1964; Traka and Mithen, 2009; Kiplimo et al., 2012; and ref. therein).
The plant is a self-sufficient organism comprised of mechanisms to feed, hydrate, and protect
itself while maintaining a semi-static location in its environment. The primary metabolic
pathways of plants, concerning their nutrition and growth, have been elucidated with the study of
plants’ primary metabolites such as carbohydrates, lipids, proteins, and nucleic acids, while
secondary metabolites and their enzymatic pathways are still undergoing much research
(Ribéreau-Gayon, 1972; Harborne, 1993; Vaistij et al., 2009; He et al., 2012; and ref. therein).
The complex role of secondary metabolites in plants is still being investigated. Regarded as
“waste products” less than fifty years ago, more recent research has found that these chemicals
help plants interact with their environment and significantly impact a plant’s health and defense
(Springob and Kutchan, 2009; and ref. therein).
Adapting over generations by natural selection, plants and their metabolic pathways have
evolved to better reproduce and protect against the environment and potential predators (Wink,
2003; and ref. therein). For these reasons, plants contain pathways to produce plant secondary
products which directly help to increase reproductive success by flavor and pigment production
and UV petal patterning (Harborne and Boardley, 1983; Owens and McIntosh, 2011; Scora and
Kumamato, 1983; Kesterson and Hendrickson, 1957; and ref therein). Secondary plant
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metabolites are compounds found in all higher plants that also function as a defense against
herbivores, microbes, viruses, and other harmful entities (Harborne, 1964; Vogt and Jones, 2000;
Wink, 2003; Ferreyra et al., 2012; and ref. therein). The accumulation of secondary metabolites,
such as phenylpropanoids, terpenoids, betacyanins, and flavonoids, improves the overall survival
and reproductive fitness of plant species (Harborne, 1993; Wink, 2003; Vaistij et al., 2009;
Ferreyra et al., 2012; and ref. therein).
II.

The Flavonoids
The McIntosh lab focuses its research

primarily on one group of secondary metabolites,
the flavonoids. Flavonoids are derived from the
amino acid phenylalanine which is formed via the
Shikimate pathway. The flavonoids are

Figure 1. Flavonoid Skeleton (Celestino et al., 2003)

subsequently formed via the phenylpropanoid pathway to produce a fifteen carbon structure
(reviewed in Harborne and Simmonds, 1964; Ribéreau-Gayon, 1972; Winkel-Shirley, 2001;
Owens and McIntosh 2011). These carbons are arranged by a multi-enzyme pathway into two
benzene rings connected by a three carbon bridge (Figure 1). This basic structure of flavonoids is
further modified by enzymes to create the subclasses of flavonoids which include chalcones,
aurones, flavanones, flavones, isoflavones, dihydroflavonols, flavonols, leucoanthocyanidins,
and anthocyanidins (reviewed in Harborne and Simmonds, 1964; Owens and McIntosh, 2011).
These subclasses differ by substitutions in ring composition. For example, flavonoid 3
hydroxylase (F3H) adds a hydroxyl group to the position 3 of the flavonoid skeleton of
dihydroflavonols, and flavonol synthase (FLS) creates a double bond on the carbon bridge to
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produce flavonols. The phenylalanine and flavonoid biosynthetic pathways can be seen in Figure
2 (Winkel-Shirley 2002).

Figure 2. Flavonoid Biosynthetic Pathway (Adapted from Winkel-Shirley 2002)
All of the subclasses have different functions within the plant and are found in an array of
different plant species (Harborne and Simmonds, 1964; Springob and Kutchan, 2009; Harborne,
1993; Winkel-Shirley 2002; and ref. therein). Flavonoids, such as anthocyanidins, are known to
help in pigment production and therefore have been found most abundantly in the outer
coverings of fruits or petals of plants (Forkman et al., 1980; Modolo et al., 2009). However
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other subclasses can be found in more abundance in the fruit tissue and leaves of plants which
are consumed by animals (Harborne, 1993; Scora and Kumamato, 1983; Berhow, 1998).
Quercetin, a flavonol, is one of the most widely distributed flavonoids in the world and can be
found in many edible plants such as apples and onions (Ribéreau-Gayon, 1972).
III.

Benefits of Flavonoids on Human Health
The flavonoids contain many properties that benefit the health of the plants as well as an

organism that consumes it (Springob and Kutchan, 2009; and ref. therein). The presence of
flavonoids in a healthy diet has made them a popular subject for possible pharmaceuticals or
medical treatments. The benefits of these naturally-occurring aromatic secondary plant
metabolites are extensive and include antioxidant, antiviral, antiallergic, antidiabetic,
cardioproctective, and anti-carcinogenic characteristics (Rice-Evans et al., 1995; Caltagirone et
al., 2000; Traka and Mithen, 2009; Toumi, 2009). Thus, the study of the synthesis and regulation
of flavonoids is vital for economic and clinical reasons.
Several clinical trials have been conducted to test possible advantageous effects of
flavonoids on heart health. The Zutphen Elderly Study, conducted in the Netherlands starting in
1960, found that flavonoid intake was significantly inversely associated with mortality from
coronary heart disease in elderly men, ages 65-84 (Hertog and Feskens, 1993). Their flavonoid
intake was controlled through a diet of tea, onions, and apples, which all contain different
subclasses of flavonoids. Overall, it was found that flavonoids inhibit the oxidation of lowdensity lipoprotein and reduce thrombic tendency (Hertog and Feskens, 1993). Epidemiology
studies reported a high dietary intake of flavonoids can also reduce the risk of heart disease
(Knekt et al., 2002). Flavonoids were also found to increase vascular relaxation in porcine
coronary arteries (Xu et al., 2007). These findings have furthered flavonoid synthesis research to
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discover compounds that could be used in pharmaceuticals or in a dietary treatment plan (Vastij
et al., 2009).
Due to their antioxidant effects, flavonoids are used in the production of many medicines
and supplements (Traka and Mithen, 2009; and ref. therein). Free radicals are produced by
normal metabolic processes and/or exposure to other sources such as ultra-violet light or smoke.
The unpaired electrons on free radical species can cause considerable cell damage and can lead
to cancer development or other chronic diseases (So et al., 1997; Middleton and Kandaswami,
1990; and ref. therein). Flavonoids are found to have free radical scavenging abilities due to their
hydroxyl group substitutions about the flavonoid skeleton (Amic et al., 2003; Rice-Evans et al.,
1995).
Flavonoids can also help control the proliferation of carcinogenic cells (So et al., 1997;
and ref. therein). For example, baicalein, galagin, hesperetin, naringenin, and quercetin were all
found to have antiproliferative activity against breast cancer cells (So et al., 1997; Caltagirone et
al., 2000). Flavones and isoflavones have also been found to prevent cancer by maintaining a
rich diet of these flavonoid compounds (Birt et al., 2001). Intake of flavonoids has been found to
reduce many types of cancer including lung and breast cancer (Zava and Duwe, 1997; Le
Marchand et al., 2000; and ref. therein).
Flavonoids have also been found to exhibit anti-HIV activity as well as inhibit HIV-I
reverse transcriptase, protease, and integrase (Wang et al., 2004; Xu et al., 2000). One study
found baicalin, a flavonoid compound from a Chinese herbal medicine, inhibited HIV infection
upon viral entry (Li et al., 2000). Some flavonoids have even been used to create drugs for
chemotherapy of the HIV infection (Vlietinck et al., 1998). These examples only shed a small
light on the plethora of flavonoid natural products that are used against the HIV infection. Again,
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this shows that the flavonoids are a popular subject for pharmaceutical research to treat many
different diseases.
Evidence has been found to suggest that flavonoids regulate cell function. This leads to a
significant immune and inflammatory response by flavonoids that aid in secretory processes,
mitogenesis, cell-cell interactions, and regulation of homoeostasis of the immune system
(Middleton and Kandaswami, 1992; Traka and Mithen, 2009; and ref. therein). The flavonoids
will continue to be studied for their health benefits to humans to further elucidate any other
medicinal implications.

IV.

Glucosylation of Flavonoids
Over 7,000 naturally-occurring flavonoids have been discovered to date (Harborne and

Simmonds, 1964; Harborne, 1993; Andersen and Markham, 2006). The basic structure lends
itself to substitutions from many types of molecules. Flavonoids can readily go under the
processes of hydroxylation, acylation, glucosylation, and many other substitutions (Harborne and
Simmonds, 1964; Ribéreau-Gayon, 1972; Winkel-Shirley, 2001). In vivo, flavonoids are found
to be highly substituted; the majority of compounds are present in glycosylated forms (Andersen
and Markham, 2006). Each substitution of the flavonoid skeleton changes the chemical
properties of the compound.
One of the final steps of flavonoid biosynthesis, glucosylation, is a significant process
because the substitution of hydrogen from the ring or hydroxyl group for a glucose molecule can
affect its toxicity, regulate homeostasis, and enhance the solubility of the compound (McIntosh
and Mansell, 1990; Bowles, 2006; Traka and Mithen, 2009; and ref. therein). The enzyme
responsible for the transfer of the glucose moiety is called a glucosyltransferase (GT). Over
10

12,000 putative glucosyltransferase sequences have been collected and appear in various
databases from different organisms including but not limited to Vitis vinifera, Arabidopsis
thaliana, and Citrus paradisi, but only around 40 GT sequences have had biochemical
confirmation of function (Owens and McIntosh, 2009; Masada et al., 2009; Vaistij et al., 2009;
and ref. therein). GTs that glucosylate plant natural products and small lipophilic molecules
belong to the GT 1 family (Vogt and Jones, 2000; Vaistij et al., 2009). Many different types of
sugars can be transferred by GTs; however, many characterized flavonoid GTs have been found
to prefer uridine diphosphate glucose (UDP-glucose) for transfer (McIntosh and Mansell, 1990;
McIntosh et. al., 1990; Owens and McIntosh, 2009; and ref. therein). GTs that are selective for
UDP-glucose are known as UGTs, and most characterized UGTs have been found to have
further substrate selectivity to prefer just one subclass of flavonoids (Li et al., 2007; Modolo et
al., 2007; Owens and McIntosh, 2009; and ref. therein).
V.

Grapefruit Model System
The model plant system used for this research is Citrus paradisi, or grapefruit. The

grapefruit plant is an ideal subject because it is known to contain many glucosylated flavonoids
(Scora and Kumamato, 1983; Dugo et al., 2005; Berhow, 1998). Grapefruit is especially rich in
flavanones and flavones (Owens and McIntosh, 2009; and ref. therein). These subclasses are
known as early flavonoids as they are produced upstream in the flavonoid biosynthesis pathway
(Harborne and Simmonds, 1964; Dean, 2003). Different amounts of flavonoids are found
throughout all different types of grapefruit tissue and stages (McIntosh and Mansell 1990;
Jourdan et al 1985; Berhow, 1998; Scora and Kumamato, 1983). In young grapefruit leaves, 4070% of the dry weight was found to be the bitter compound naringin (McIntosh and Mansell,
1990; Jourdan et al., 1985; Kesterson and Hendrickson, 1957). Some speculate that this
11

compound in the young grapefruit tissue has a bitter taste for defense (Del Rio et al., 1998). It
has been discovered that when a rhamnose sugar is added to naringenin 7-O-glucoside, based on
the substitution site, it can change the flavor composition to bitter naringin or tasteless narirutin.
Tasteless linkages are found in non-bitter species, such as Citrus reticulata and Citrus sinensis.
Both linkages, bitter and tasteless, are found within Citrus paradisi (Frydman et al., 2004;
Jourdan et al., 1985; Kesterson and Hendrickson, 1957, Barthe et al., 1987, Berhow 1998). The
effect of glycosylation on taste makes it a popular subject of research for the citrus industry
(Horowitz and Gentili, 1969; Shaw et al., 1984; Drewnowski et al., 2001; Mansell and McIntosh,
1991; Mansell et al., 1983; Jourdan et al., 1985; Barthe et al., 1987).
VI.

Putative Glucosyltransferase 4
Various putative glucosyltransferase clones studied in our lab, in particular the one

presented in this research, were obtained from a young grapefruit leaf cDNA library (Roy Sarkar
et al., 2007). Degenerate primers were designed against the PSPG (Plant Secondary Product
Glucosyltransferase) box, a forty-four amino acid sequence unique to glucosyltransferases. Smart
Race RT-PCR was used to amplify 5’ clones, and then clone specific primers were designed to
“walk out” the sequences and find the 3’ ends (Sibhatu, 2003; Roy Sarkar, 2004; Roy Sarkar et
al., 2007; Strong, 2005) All clones had a high identity with other glucosyltransferases within the
PSPG box region and a low identity outside the PSPG box region (Roy Sarkar et al, 2007).
Figure 3 shows the PGT 4 with the start and end of PSPG box region marked with arrows.
1
1

ATG GCA TCC GAA GCC AGC CAG GTT CAC TTT CTC TTG CTT CCT TAC
Met Ala Ser Glu Ala Ser Gln Val His Phe Leu Leu Leu Pro Tyr

45
15

46
16

TTG GCT CCA GGC CAC TTG ATT CCC ATG TTT GAC ATT GCT AGA TTG
Leu Ala Pro Gly His Leu Ile Pro Met Phe Asp Ile Ala Arg Leu

90
30

91
31

CTT GCA CAG CAT GGA GCT ATT GTT ACT ATT GTC ACC ACC CCA GTT
Leu Ala Gln His Gly Ala Ile Val Thr Ile Val Thr Thr Pro Val

135
45

12

136
46

AAT GCG GCA AGG TTC AAA ACA GTG ATT GCT CGT GCA ATA AAA TCC
Asn Ala Ala Arg Phe Lys Thr Val Ile Ala Arg Ala Ile Lys Ser

180
60

181
61

GGC CTA CAA ATC CGA CTA ATT GAG ATC CAG TTT CCT TGG CAA GAA
Gly Leu Gln Ile Arg Leu Ile Glu Ile Gln Phe Pro Trp Gln Glu

225
75

226
76

GCA GGA ATA CCT GAA GGT TGT GAG AAT TGT GAC TTG CTT CCT ACA
Ala Gly Ile Pro Glu Gly Cys Glu Asn Cys Asp Leu Leu Pro Thr

270
90

271
91

ACA GAC TTT GCA AGG TTC ATG AAG TCG CTT CAC ATG CTT CAA CAG
Thr Asp Phe Ala Arg Phe Met Lys Ser Leu His Met Leu Gln Gln

315
105

316
106

CCT TTT GAA AAT TTG TTC AAA GAG AAA ACT CTT AAG CCC TGC TGC
Pro Phe Glu Asn Leu Phe Lys Glu Lys Thr Leu Lys Pro Cys Cys

360
120

361
121

ATA ATC TCT GAC ATG TGT TTT CCT TGG ACG GTG GAT ACA GCT GCC
Ile Ile Ser Asp Met Cys Phe Pro Trp Thr Val Asp Thr Ala Ala

405
135

406
136

AAG TTC AAT GTT CCA AGG ATT ATT TTC CAT GGA TTT TCT TGC TTC
Lys Phe Asn Val Pro Arg Ile Ile Phe His Gly Phe Ser Cys Phe

450
150

451
151

TGT CTC TTC TGT CAT CAC CTC TTG GGT GTT TCA AAG GTT CAC GAG
Cys Leu Phe Cys His His Leu Leu Gly Val Ser Lys Val His Glu

495
165

496
166

AAT GTT ACT TCT GAT TCA GAG TAC TTT AAT ATA CCT GGA TTG CCT
Asn Val Thr Ser Asp Ser Glu Tyr Phe Asn Ile Pro Gly Leu Pro

540
180

541
181

GAT CAC ATT CAA TTT ACT AAA GTT CAA TTA CTA ATA TCC AAG CGG
Asp His Ile Gln Phe Thr Lys Val Gln Leu Leu Ile Ser Lys Arg

585
195

586
196

GAT GAT GAC CGT AAA GAG CTT CGA GAG CAA ATT TTG GCG GCC GAT
Asp Asp Asp Arg Lys Glu Leu Arg Glu Gln Ile Leu Ala Ala Asp

630
210

631
211

AAG AAA ACA TAC GGC GCG ATT ATA AAT ACC TTC GAA GAG CTA GAG
Lys Lys Thr Tyr Gly Ala Ile Ile Asn Thr Phe Glu Glu Leu Glu

675
225

676
226

TCG CCA TTT ATT GAA AAC TAC AAA AAA GCC GAA CAA GGA AAA GTT
Ser Pro Phe Ile Glu Asn Tyr Lys Lys Ala Glu Gln Gly Lys Val

720
240

721
241

TGG TGC ATC GGC CCT GCT TCG CTG TGC AAC AAA GAG CCC ATA GAC
Trp Cys Ile Gly Pro Ala Ser Leu Cys Asn Lys Glu Pro Ile Asp

765
255

766
256

AAG GCA GAG AGA GGT AAA ACA GCA TCA ATT GAT GTT CCT GAA TGC
Lys Ala Glu Arg Gly Lys Thr Ala Ser Ile Asp Val Pro Glu Cys

810
270

811
271

TTA ACA TGG CTT GAT TCA CAG CAG CCA AGC TCA GTA GTC TAT GTT
Leu Thr Trp Leu Asp Ser Gln Gln Pro Ser Ser Val Val Tyr Val

855
285

856
286

TGT CTT GGA AGC ATC TGT AAC TTG CCA TCT TCA CAA CTT ATA GAG
Cys Leu Gly Ser Ile Cys Asn Leu Pro Ser Ser Gln Leu Ile Glu

900
300

901
301

CTC GGT TTA GGC CTT GAA GCA TCT AAC AAA CCG TTT GTT TGT GTT
Leu Gly Leu Gly Leu Glu Ala Ser Asn Lys Pro Phe Val Cys Val

945
315

946
316

ATC AGG GGA GTG AGT AAA TTA GAA GCA TTA GAG AAG TGG CTT GTA
Ile Arg Gly Val Ser Lys Leu Glu Ala Leu Glu Lys Trp Leu Val

990
330

991
331

CAA GAA AAT TTT GAA GAA AGG ATT AAA GGA AGA GGC CTA TTG ATT
Gln Glu Asn Phe Glu Glu Arg Ile Lys Gly Arg Gly Leu Leu Ile

1035
345

1036
346

CGG GGT TGG GCA CCA CAA GTA TTG ATA TTA TCA CAC CCT GCA GTC
Arg Gly Trp Ala Pro Gln Val Leu Ile Leu Ser His Pro Ala Val

1080
360

1081
361

GGA GGG TTC TTA ACG CAT TGC GGC TGG AAT TCA TCT CTG GAA GGG
Gly Gly Phe Leu Thr His Cys Gly Trp Asn Ser Ser Leu Glu Gly

1125
375

1126
376

ATA TCA GCT GGG GTT CAA ATG CTT ACA TGG CCA CTC TTT GCA GAC
Ile Ser Ala Gly Val Gln Met Leu Thr Trp Pro Leu Phe Ala Asp

1170
390

13

1171
391

CAA TTT TGC AAT GAG AAG TTG ATT GTG AAT GTT TTA AGG ATT GGT
Gln Phe Cys Asn Glu Lys Leu Ile Val Asn Val Leu Arg Ile Gly

1215
405

1216
406

GTG AGT GTT GGA GTG GAA GTT CCA ATG AAT TTT GGA GAA GAA GAG
Val Ser Val Gly Val Glu Val Pro Met Asn Phe Gly Glu Glu Glu

1260
420

1261
421

AAG ATT GGA GTA TTG GTG AAT AAG GAA AAT GTC AAA ACG GCT ATA
Lys Ile Gly Val Leu Val Asn Lys Glu Asn Val Lys Thr Ala Ile

1305
435

1306
436

AAC ATA CTG ATG GAT GAT GGA GAG GAA AGA AAT GCG AGA AGA AGT
Asn Ile Leu Met Asp Asp Gly Glu Glu Arg Asn Ala Arg Arg Ser

1350
450

1351
451

GCC AGA GAG TTT GGA GAG TTG GCT AAA AGA GCT ATA GAT GAA GGT
Ala Arg Glu Phe Gly Glu Leu Ala Lys Arg Ala Ile Asp Glu Gly

1395
465

1396
466

GGA TCT TCC TAT AAC AAC GTC GAA TTA TTT ATG CAA GAT ATC ATG
Gly Ser Ser Tyr Asn Asn Val Glu Leu Phe Met Gln Asp Ile Met

1440
480

1441
481

CAA CAG CCG AGC TCA GAA GTG ATT TAA
Gln Gln Pro Ser Ser Glu Val Ile End

1467

Figure 3. Amino Acid Sequence of PGT 4 with arrows denoting the start and end of the Plant Secondary
Product Glucosyltransferase (PSPG) Box.

The focus of this research is the study of one putative glucosyltransferase clone, PGT 4
(Figure 3). The PGT 4 sequence consists of 1467 base pairs, and the PGT 4 protein has a
predicted molecular weight of 54 kD. This size is within the normal range observed for the
majority of plant GTs (McIntosh and Mansell, 1990; McIntosh et al., 1990; Durren and
McIntosh, 1999; Owens and McIntosh, 2009; and ref. therein).
Once the 5’ and 3’ ends of the PGT 4 clone had been determined, it was then cloned into
a bacterial vector, pCR® 4-TOPO® (Invitrogen) by previous researchers, Christy Strong and
Leslie Epling (Strong, 2005; Epling, 2007). Josephat Asiago cloned PGT 4 into the pCD1 vector,
a modified version of the pET-32A cloning vector with an engineered thrombin cleavage site to
remove the tags for better purification upon expression (Winkel, VA Tech). Once the presence of
PGT 4 was confirmed within pCD1, Asiago screened for flavonoid glucosyltransferase activity
of PGT 4 expressed in E.coli, but little to no activity was found. Inclusion bodies, vacuoles in
bacteria that store expressed proteins, rendered much of the expressed protein insoluble and
unable to be active. Thus, PGT 4 has now been cloned into the pPICZA vector (Invitrogen;
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Sanje Roje, WSU) and transformed into Pichia pastoris, a eukaryotic system, to eliminate the
problems with inclusion bodies and insoluble protein and to again test for flavonoid
glucosyltransferase activity. This research was conducted with the hypothesis that PGT 4 would
glucosylate flavonoid substrates, acting as a flavonoid glucosyltransferase.
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MATERIAL AND METHODS
I.

Materials
Chemicals and Reagents
Agarose, agar, yeast extract, tryptone, yeast nitrogen base powder, and sodium chloride
were used in making liquid media (Fisher Scientific, Fairlawn, NJ). Ampicillin (Fisher
Scientific) and zeocin™ (Research Products Int. Corp., Mt. Prospect, IL) were needed to make
media and agar plates with antibiotics. Ethidium bromide, EtBr (10 mg/mL), was used to
visualize DNA in gel electrophoresis. One kb DNA Ladder (Fisher Scientific) was utilized to
verify DNA band lengths. Go Taq DNA Polymerase, 5 X green/colorless buffer, and
deoxyribonycleotide triphosphates (dNTPs) were used for polymerase chain reactions (Promega
Madison, WI). T4 DNA ligase enzyme, ligation buffer, restriction enzymes Apa I, Kpn I, EcoRI,
Not I (Promega, Madison, WI), and clone specific primers (Integrated DNA Technology,
Coralville, Iowa) were utilized for clone reconstruction and DNA cloning. Tris base,
tetramethylethelynediamine (TEMED, electrophoresis grade), ammonium persulfate (APS), 40%
acrylamide solution (acrylimide:bis-acrylamide, 19:1), coomassie brilliant blue, and glacial
acetic acid were purchased from Fisher Scientific. Nitrocellulose membrane (0.45 μm pore size)
was bought from Thermo Fisher Scientific, Waltham, MA. Whatman chromatography paper
(3MM CHR), 5-bromo-4-chloro-3’-indolyphosphate p-toludine salt (BCIP) and nitro-blue
tetrazolium chloride (NBT), (Fisher Scientific) were used for protein gels and Western blots.
Monoclonal mouse c-myc antibody and goat, anti-mouse IgG alkaline phosphatase (AP)
conjugates were purchased from Novagen (Madison, WI). The Mini-PROTEIN Tetra gel
electrophoresis system, micropulser cuvettes, and Silver Stain Kit were purchased from Bio-rad
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(Hercules, CA). Lyticase enzyme (from Arthobacter leutus) and acid-washed glass beads (pore
size 0.5 mm) were purchased from Sigma Aldrich (St. Louis, MO). Coomassie® R-250 for
protein gel staining was purchased from Life Technologies™ (Grand Island, NY).
Cells and Vectors
The pCD1 vector was obtained from Brenda Winkel of the Virginia Polytechnic Institute
and State University (Blacksburg, VA). The pCR® 4-TOPO® vector and One Shot® Top Ten
Chemically Competent Cells were purchased from Invitrogen (Carlsbad, CA). The pPICZA
vector and X33 parent strain of Pichia pastoris were a gift from Sanja Roje of Washington State
University (Pullman, WA). Competent yeast cells were prepared following the protocol from the
Invitrogen Easy Select™ Pichia Expression Kit.
Kits
The QIAprep® Spin Miniprep Kit was purchased from Qiagen (Valencia, CA). The
Wizard® SV Gel and PCR Clean-Up System was purchased from Promega. The Quantum Prep®
Plasmid Midiprep Kit was purchased from BIO-RAD. The TOPO TA Cloning® Kit was
purchased from Invitrogen.
Buffers
All of the following buffers were prepared by recipes in Appendix A. TAE (Tris-Acetate
EDTA) was prepared for DNA electrophoresis. One molar potassium phosphate (pH 6) was
prepared for growth media. TANK Buffer (pH 8.3), TBS buffer, AP buffer (pH 9.5), 1 mM
PMSF (phenylmethylsulfonyl fluoride), 1 mM EDTA (ethylenediaminetetracetic acid), breaking
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buffer transfer buffer, blocking solution, developing solution, and stop buffer were all prepared
for SDS-PAGE and Western blot analysis.
Culture Media
Low salt LB (Luria-Bertani) liquid media and LB agar plates were prepared as described
in Appendix B. YPD (yeast, peptone, dextrose) liquid media and YPDS (yeast, peptone,
dextrose, and sorbitol) agar plates were prepared as described in Appendix B. Buffered glycerolcomplex media (BMGY) and buffered methanol-complex media (BMMY) were prepared as
described in Appendix B.
Flavonoids and Phenolic Substrates for Enzymes Assays
Naringenin, hesperitin, eriodictyol, isosakuranetin, apigenin, luteolin, diosmetin,
scutallerein, kaempferol, quercetin, fisetin, gossypetin, 4’ methoxyflavonol, 4’-acetoxy-7hydroxy-6-methoxy isoflavanone were purchased from Sigma and Indofine.
II.

Methods
Clone Specific Primer Design
Based on the BioEdit (Ibis Biosciences, Carlsbad, CA) file received from Dr. Daniel
Owens, clone specific primers for putative glucosyltransferase 4 were designed in order to
amplify the sequence by polymerase chain reaction (PCR). The primers were designed as shown
below (Table 1).
Table 1. PGT 4 Clone Specific Primer Sequences for PCR Amplification. The bolded
nucleotides correspond to the restriction enzyme cutting site in each primer.
Rest.
Primer
Sequence
Enzyme
CSP 144 F 5’ CAT GGG TAC CAT GGC ATC CGA AGC CAG CCA 3’
Kpn I
CSP 145 R 5’ CGC GGG CCC AAT CAC TTC TGA GCT CGG CTG 3’
Apa I
18

Annealing

Temp.
62.3 oC
64.3 oC

The restriction enzymes chosen were to help facilitate cloning into the pPICZA vector as
Apa I and Kpn I are located within the vector’s multiple cloning site (Invitrogen). The primers
were ordered from Integrated DNA Technology through the ETSU Quillen College of Medicine
Molecular Biology Core Facility (Johnson City, TN).
Low Salt LB Liquid Media Culture
E.coli cultures were grown from Josephat Asiago’s glycerol stocks of PGT 4 stored at
-80oC. Various glycerol stocks were chosen to verify the sequence of PGT 4. Low salt LB liquid
media was made according to the recipe in Appendix B. The glycerol stocks were saved in the
pCR® 4-TOPO® vector (Invitrogen) which has an ampicillin resistance. Ampicillin was added
to the LB media to produce a final concentration of 100 mg/L. LB liquid media with antibiotic
was inoculated with a dab of glycerol stock using an autoclaved toothpick or pipet tip. Cultures
were inoculated overnight, 12-16 hours, in a New Brunswick Shaker Incubator at 250 rpm at 37
o

C.

Isolation of DNA Plasmid
The QIAprep® Spin MiniPrep Kit was used to isolate DNA plasmid from the LB liquid
media cultures. Five milliliters of culture were used for each MiniPrep. The cells were
centrifuged in autoclaved centrifuge tubes (Fisher Scientific) in a Sorvall® Biofuge pico
microcenterfuge, and the Qiagen protocol was followed to isolate the DNA plasmid. Fifty μL of
DNA was isolated from each MiniPrep and was labeled and stored at -20 oC.
DNA Gel Electrophoresis
Thirty mL 0.8% agarose gels were made to verify the presence of plasmid DNA in the
MiniPreps and to verify the vector length by comparison to the 1 kb DNA ladder (See recipe in
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Appendix C). Two and a half μL ethidium bromide (10 mg/mL) were added to each gel before
solidification in order to view the DNA with a UV illuminator. The gel was cooled in an
electrophoresis cell (Owl Separation Systems, Inc., Portsmouth, NH) and each well was loaded
with 6μL of a mixture including 2μL DNA, 1μL 6Xdye, and 3μL distilled water in each lane.
The electrophoresis cell was run for one hour at 100 volts. The gels were viewed in an Epi Chem
II Darkroom from UVP Bioimaging Systems and images saved as computer files for later use.
DNA Sequencing
Once the presence of DNA plasmid in the MiniPreps was confirmed, an aliquot was sent
to the Molecular Biology Resource Facility of the University of Tennessee in Knoxville, TN for
sequencing. The DNA sequencing results were sent via electronic mail in BioEdit files. The files
were compared with the PGT 4 sequence obtained from Dr. Daniel Owens. Upon alignment of
all the glycerol stocks sent for sequencing, it was found that not one of the glycerol stocks
contained the full length PGT 4 sequence. All of the stocks were partial clones.
Reconstruction of Full-length PGT 4
Different glycerol stocks from Josephat Asiago
were grown. DNA plasmid was isolated and sent
for sequencing to try to find a stock of the full
length PGT 4 clone. After sequencing several
glycerol stocks and finding only partial clones,
glycerol stocks from Christy Strong were grown,
and the isolated DNA was sequenced. The
glycerol stocks labeled 181.2A and 155.1A

Figure 4. pCR® 4-TOPO® vector map (Invitrogen)

contained partial PGT 4 clones in the pCR® 4-TOPO® vector, but each contained significant
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pieces. A strategy was devised to cut and ligate the pieces together. To perform a directed
ligation, it is necessary to have a unique cutting site. However, it was discovered that only one
enzyme could cut the two partial clones in the desired range to ligate them together. A challenge
arose. EcoRI was needed to internally cut the partial clones, but it is located on both sides of the
pCR® 4-TOPO® vector multiple cloning site (Figure 4).
Primer Design
With the multiple EcoRI cutting sites within the pCR® 4-TOPO® vector multiple cloning
site, the PGT 4 partial clones (181.2A and 155.1A) needed to be amplified outside the pCR® 4TOPO® vector. Thus, primers were designed to PCR amplify the partial clones out of their
vector, and restriction enzymes were chosen to easily clone PGT 4 into pPICZA after the
reconstruction. Figure 5 below shows the schematic for the reconstruction of PGT 4 with the
designed primers. Table 2 shows the clone specific primer sequences designed to PCR amplify
the pieces out of the pCR® 4-TOPO® vector.

Figure 5. Plan for the Reconstruction of PGT 4 Four clone specific primers were designed against the
partial clones to amplify them out of the pCR® 4-TOPO® vector. The internal EcoRI site was used to

ligate the two pieces together within an empty pCD1 vector.
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Table 2. Primer Design for PCR Amplification out of pCR 4-TOPO vector.

Bolded bases represent restriction enzyme cutting sites for each primer.
Primer
CSP 144 F
CSP 149 R
CSP 150 F
CSP 151 R

Sequence
5’ CATG GGTACC ATG GCA TCC GAA GCC AGC CA 3’
5’ GAT GAATTC CAG CCG CAA TGC GTT AAG AAC CCT 3’
5’ CTG GAATTC ATC TCT GGA AGG GAT ATC AGC TGG GGT TCA 3’
5’ CGC GCGGCCGC AAT CGC TTC TGA GCT CGG CTG TTG 3’

Rest.
Site
KpnI
EcoRI
EcoRI
NotI

Annealing
Temp.
62.3 oC
64.8 oC
65.8 oC
61.6 oC

The strategy to reconstruct the PGT 4 clone was to PCR amplify the two partial clones
and insert the digested, gel purified PCR product into an empty pCD1 vector one at a time to
reconstruct the PGT 4 clone successfully. Below is a flow chart of the plan used to reconstruct
the PGT 4 clone (Figure 6).

Figure 6. Plan for the Reconstruction of PGT 4. The flow chart shows the process
used to reconstruct the PGT 4 clone from the two partial clones in an empty pCD1 vector.
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PCR Amplification
To amplify the 181.2A and 155.1A partial clones via PCR, the following contents were
added into a PCR tube: 2.5 μL of 1000 fold dilution of MiniPrep DNA of 181.2A or 155.1A
(0.001μg/μL), 10μL of 5X green Go-Taq buffer, 2.5 μL of 20μM sense primer, 2.5 μL of 20μM
antisense primer, 1.0 μL of Go-Taq polymerase, 31μL of distilled, sterile water to total a 50 μL
PCR reaction. The annealing temperature varied with the primers, which have relatively close
annealing temperatures to avoid PCR mistakes. The PCR reaction was carried out in the
MyCycler thermocycler (Bio-Rad), which was set up with the protocol below (Table 3).

Table 3. Temperature Protocol for Polymerase Chain Reaction
Step
Temperature (oC)
1
94
2
94
3
60
4
72
5
72

Time
1 minute
30 seconds
30 seconds
2 minutes
3 minutes

30 X

Gel Extraction and Purification
After the PCR reaction was complete, the PCR products were loaded into lanes of a 0.8%
agarose gel, as previously described. The gel electrophorised for an hour at 100 volts and was
viewed on a Spectroline® Transilluminator with a 302 nm UV light (Westbury, NY). A
sterilized metal razor was used to excise the desired band out of the agarose gel. The desired
181.2A product was 1100 base pairs, while the 155.1A piece was around 350 base pairs. Their
lengths were determined in comparison to the 1 kb ladder, run in the first lane of the gel. The
bands were put into separate sterile micro centrifuge tubes, labeled, and DNA extracted using the
protocol of the Wizard® SV Gel and PCR Clean-Up System (Promega Madison, WI). The DNA
was eluted into 50 μL of sterile, distilled water and stored at -20 oC.
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Digestion of PCR Product and pCD1 vector
The DNA concentrations of the purified gel bands were tested using the NanoDrop
spectrophotometer (Thermo Scientific). For each digestion, 1 μg of DNA was used. The 181.2A
PCR product and empty pCD1 vector were both digested with KpnI and EcoRI. To set up a
digestion, 1 μg of DNA, 1μL of each enzyme, 2 μL enzyme-specific 10Xbuffer, and 0.2 µL BSA
for stabilization was added to a varied amount of sterile, distilled water to a total reaction volume
of 20 μL. Digestions were incubated at 37 oC in a water bath or incubator for three hours. The
digestion was halted by putting the reactions in the 65 oC water bath for five minutes. The
digestion products were combined with 4 μL of 6Xdye and added to the lanes of an agarose gel.
The desired bands were extracted and purified as discussed previously.
Ligation of 181.2A into the pCD1 vector
The concentration of the purified, digested DNA was tested using the NanoDrop. The
insert, 181.2A, had a concentration of 8.1 ng/ μL, and the vector, pCD1, had a concentration of
17.9 ng/μL. These concentrations were used to setup a ligation of the two pieces to make a
circular DNA plasmid. The following calculations were made using an online ligation calculator
(Collins, 2011: http://django.gibthon.org/tools/ligcalc/). The three ratios were used to optimize
ligation conditions. Having a higher concentration of insert:vector is useful when performing a
ligation. The ligation mixtures were added to sterile PCR tubes and left at 4 oC overnight. For
each ligation, the insert and vector had varying concentrations thus the ratios shown may seem
skewed.
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Table 4. Ligation Ratios for Insertion of 181.2A into pCD1
Ratio (Insert:Vector)
1:1
3:1
Insert DNA (µL)
4.1
8.2
Vector DNA (µL)
10
6.8
Ligase (µL)
1.0
1.0
Ligase Buffer (µL)
4.0
4.0
Sterile, distilled water (µL)
0.9
0.0

6:1
10
4.1
1.0
4.0
0.9

Transformation of Ligated 181.2A and pCD1
Once the ligated product had been at 4 oC for at least twelve hours, a transformation was
performed. Following the Invitrogen protocol for One Shot® Top Ten Chemically Competent
Cells, the cells were thawed and 10 μL of ligated product of each ratio was added to a different
tube of Top 10 cells. A control of undigested vector plasmid was also inoculated into a tube of
competent cells. The cells were incubated on ice for 30 minutes and then heat shocked for 30
seconds at 42 oC. Then, 250 μL of low salt LB media was added to each tube, and they were
shaken for an hour at 225 rpm at 37 oC. One hundred μL of each tube was plated with a sterile
tool onto LB agar plates with an ampicillin concentration of 100mg/L. (See Appendix B for LB
agar plate recipe.) The LB agar plates were kept at 37 oC overnight and checked for colonies the
next day.
PCR Check for Insertion of 181.2A
A test was performed to confirm the presence of 181.2A in pCD1 before isolated DNA
plasmid was sent off for sequencing. Four colonies were found on the 3:1 ratio plate the next
day. An autoclaved pipet was used to collect cells from each colony and diluted into 10 μL to use
as DNA template for the PCR reaction. A PCR reaction was setup by loading a PCR tube with 1
μL of 1000 fold dilution of MiniPrep DNA of pCD1+181.2A (0.001μg/μL), 2 μL of 5X green
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Go-Taq buffer, 0.5 μL of 20μM sense primer, 0.5 μL of 20μM antisense primer, 1.0 μL of GoTaq polymerase, 5 μL of distilled, sterile water to total a 10 μL PCR reaction. The PCR reaction
was run with an annealing temperature of 60 oC, and 2 μL of 6Xdye was added to the PCR
product and loaded into lanes of a 0.8% agarose gel. Illumination of the gel showed bands at
1100 bp in two of the four colonies suggesting the presence of 181.2A insert in pCD1. These
colonies were inoculated into LB liquid media with amp (100mg/L) and grown overnight at 37
o

C and 250 rpm. Plasmid DNA was isolated the next day and sent to UTK for sequencing.

Insertion of 155.1A into pCD1+181.2A vector
Upon confirmation of the first insert, the 155.1A PCR product and the pCD1+181.2A
vector were digested with EcoRI and NotI to insert the second piece and reconstruct the PGT 4
clone. The same digestion protocol was followed as discussed previously. The 20 μL digestion
was loaded into a well of a 0.8% agarose gel. After running the gel at 100 volts for an hour,
correct bands were extracted and purified. The concentrations of the vector and 155.1A insert
were found using the Nano Drop method. The partial clone, 155.1A, was 7.3 ng/ μL, and the
vector+181.2A was 6.1 ng/μL. A ligation was set up between the two pieces using an online
ligation Calculator (Collins, 2011; http://django.gibthon.org/tools/ligcalc/). To a sterile PCR tube
the following was added: 4 µL ligase buffer, 1 μL ligase, 10 μL vector, 1.1 μL insert, and 3.9 μL
distilled water. The ligation was incubated overnight at 4oC. A transformation was performed
the next day following the same protocol as discussed above. LB agar plates with transformants
were left at 37 oC overnight for colonies to grow. Nine colonies were found the next day and
were tested to confirm the insertion of the 155.1A piece. The same protocol for a PCR was used
as before. When the gel with PCR products was illuminated one colony had the full 1467 base
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pair sequence of PGT 4. This colony was inoculated into LB amp (100mg/L) media and grown
overnight. The DNA plasmid was isolated the next day and sent for sequencing at UTK. The
sequencing results confirmed the reconstruction of full-length PGT 4 in the pCD1 vector.
Cloning into the pPICZA vector
Upon the reconstruction of PGT 4, the clone was able to be cut out of the pCD1 vector
and inserted into the pPICZA vector to be transformed into yeast. The restriction enzymes
chosen to create the primers were chosen with the pPICZA multiple cloning site in mind. Thus,
the sense and antisense primers of the newly reconstructed PGT 4 sequence included KpnI and
Not I sites. The same sites were also found in pPICZA in a manner in which PGT 4 could be
directionally cloned into pPICZA without having to design new primers.
To clone into pPICZA, the same processes were used as in the case of pCD1. The pCD1
vector containing the PGT 4 sequence was digested with KpnI and NotI to isolate the PGT 4
band. Empty pPICZA vector was also digested with KpnI and NotI. The vector and PGT 4 insert
bands were extracted and purified. Then, an online ligation calculator was used to setup the three
ratios for ligation (Collins, 2011; http://django.gibthon.org/tools/ligcalc/). The ligation set up is
detailed in Table 5.
Table 5. Ligation of PGT 4 and pPICZA
Ratio (Insert:Vector)
1:1
Insert DNA (µL)
6.5
Vector DNA (µL)
8.5
Ligase (µL)
1.0
Ligase Buffer (µL)
4.0
Sterile, distilled water (µL)
0.0

3:1
10.0
4.3
1.0
4.0
0.7

6:1
10.0
2.2
1.0
4.0
2.8

The next day, the ligation products were transformed into One Shot® Top 10 Chemically
Competent Cells. After incubating for 24 hours at 37 oC, there were 12 colonies on the three
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plates. Following a PCR Check, it was found that five colonies had the PGT 4 sequence
successfully inserted into the pPICZA vector. These five colonies were inoculated into LB zeocin
(25mg/L) media and grown overnight. The DNA plasmid was isolated by MiniPrep the next day
and sent to UTK for sequencing. The sequencing results showed that the PGT 4 sequence had
been inserted correctly; however, the myc epitope and polyhistidine tags of the pPICZA vector,
directly following the 3’ end of the PGT 4 insertion, were out of frame. The myc epitope and
polyhistidine tags are essential for enzyme purification, thus it was imperative that the codons
encoding the amino acids to make these tags were in frame. A single base pair insertion was
needed to bring the tag sequences in frame. To keep the tags in frame, the clone specific primer
needed to be a multiple of three to not frameshift the tags in the pPICZA vector sequence
following PGT 4. Figure 7 shows the sequence before and after the single insertion.

Primer Modification for Addition of Base Pair
Two new primers were designed to amplify the PGT 4 sequence to be in frame within
pPICZA. The 5’ primer sequence (CSP 163F) was the same as the original CSP 144F with a few
changes. The beginning first three base pairs were altered to correspond with the pPICZA vector
to help anneal the primer to the sequence for amplification. Also, additional base pairs were
added at the end of the 5’ primer sequence to match the melting temperature of the 3’ primer and
increase probability of correct PCR amplification. Only one base had to be added to the 3’
primer sequence (CSP 164R) to frameshift the tags (Table 6). Thus, using the original primer
design of CSP 151 R, one “G” was added directly after the final codon of the PGT clone, an
isoleucine, and directly before the Not I restriction site of the clone specific primer. Figure 7
shows the sequence before and after the single insertion.
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B

Figure 7. Frameshift in purification tag sequences due to clone specific primer.
A. This figure shows the sequence with out-of-frame tags. The presence of multiple isoleucines
in the second line instead of the histidine tag is seen. B. This figure shows the sequence with the
insertion of a “G” at base pair 1465. This insertion caused the tags to be in frame and the
histidine tag is clearly seen on the second line followed by the stop codon

Table 6. This table displays the newly designed primers to amplify PGT 4 to be in frame within
pPICZA. The bolded base pair shows the insertion. The 3’ primer is designed as the
complementary sequence. Thus, the addition of a “C” within the primer sequence will result in
the addition of a “G” into the sequence to frameshift the sequence following the 3’ end that
codes for vital tags to aid in identification and purification of the protein.
Primer

Sequence

CSP 163 F
CSP 164 R

5’ATC GGT ACC ATG GCA TCC GAA GCC AGC CAG GTT 3’
5’ CTG GCG GCC AAT CAC TTC TGA GCT CGG CTG TTG CA 3’

Rest.
Enzyme
KpnI
NotI

TM
(oC)
62.3
64.3

PCR Amplification of Recombinant PGT 4
PCR amplification was performed with the newly designed primers (Table 6). Three PCR
tubes were loaded with: 12.5 μL 2 X PCR Master Mix (see Appendix B for recipe), 0.5 μL CSP
163 F, 0.5 μL CSP 164R, 1000X isolated PGT 4 in pPICZA plasmid (the correct but out of
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frame sequence), and 11.25 µL sterile, distilled water. The reactions were inserted into the
Eppendorf thermocycler and run with the same protocol as in Table 3. The PCR products were
loaded onto a 0.8% agarose gel and run at 100 volts for 1 hour. The bands were visualized with
UV light and extracted from the gel using a sterile blade. The PCR product was purified using
the protocol of the Wizard® SV Gel and PCR Clean-Up System (Promega). The DNA was eluted
into 50 μL of sterile, distilled water and stored at -20 oC.
TOPO TA Cloning of PGT 4
The PCR product was used for TOPO TA Cloning® following the Invitrogen protocol: 4
µL of PCR product was mixed with 1 µL empty TOPO ® vector and 1 µL TOPO ® salt solution
and incubated at room temperature for 30 minutes. Two µL of this solution were added to a
thawed tube of One Shot® Top 10 Chemically Competent Cells. The cells were incubated on ice
for 5 minutes, heat shocked for 30 seconds in a 42 o C water bath, and then incubated on ice for 2
minutes. With this protocol, the PCR product is rapidly ligated into the vector and does not need
an extended incubation period. After adding 250 µL LB media, the cells were shaken for an hour
at 225 rpm and 37 oC. Varying amounts of the sample (25, 50, 100, 200 µL) were plated onto
LB amp (100mg/L) agar plates and incubated at 37 oC overnight. A positive control was also
conducted using 1 µL PUC19 in an additional tube of One Shot® Top 10 Chemically Competent
Cells. The next day, four colonies were found on the selective LB plates. The insertion of the
PCR product was confirmed by a PCR screen using the new clone-specific primers, CSP 163F
and CSP 164R (Table 6).
Cloning into pPICZA with PGT 4 Base Insertion
A digestion of PGT 4 in TOPO and empty PICZA plasmid was conducted with KpnI and
NotI. With the same setup as mentioned before, the digestions were left at 37 oC for three hours,
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and then placed in the 65 oC water bath for five minutes to stop the reaction. The digestion
products were loaded onto a 0.8% agarose gel and run at 100 volts for an hour. The desired
bands were extracted and purified using the protocol of the Wizard® SV Gel and PCR Clean-Up
System (Promega). The DNA was eluted into 50 μL of sterile, distilled water and stored at -20
o

C. The concentrations of the pPICZA vector and PGT 4 insert were measured using the

NanoDrop and found to be 11.9 ng/μL and 2.9 ng/μL, respectively. A ligation reaction was set
up using an online ligation calculator (Collins, 2011; http://django.gibthon.org/tools/ligcalc/) and
incubated at 4oC overnight (Table 7).
Table 7. Ligation of pPICZA and PGT 4 with base insertion
Ratio (Insert:Vector)
1:1
3:1
Insert DNA (µL)
9.8
10.0
Vector DNA (µL)
5.2
1.8
Ligase (µL)
1.0
1.0
Ligase Buffer (µL)
4.0
4.0
Sterile, distilled water (µL)
0.0
3.2

6:1
10.0
0.9
1.0
4.0
4.1

The ligated products were transformed into OneShot® Top 10 Chemically Competent
Cells using the manufacturer’s protocol (Invitrogen). Each plate had a large number of colonies.
Sixteen were chosen at random; this is the number that can fit in the lanes of one agarose gel
with a negative and positive control and two lanes of 1 kb ladder. Of these sixteen colonies tested
with PCR, only two had a band at around 1500 signifying the presence of the PGT 4 insert. The
colonies were inoculated into LBZeocin (25mg/L) media and grown overnight. The DNA plasmid
was isolated by MiniPrep and sent for sequencing. The results from UTK showed that the
insertion was successful and that the myc epitope and polyhistidine tags of pPICZA were in
frame. The full PGT 4 sequence with tags in frame is shown in Figure 8.
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Isolation of DNA Plasmid for Linearization
To transform PGT 4 into yeast, 5-10 μL of linearized DNA is required (EasySelectTM
Pichia Expression Kit). To obtain a sufficient amount of DNA to linearize, a Quantum Prep®
Plasmid Midiprep was performed following the manufacturer’s protocol (BIO-RAD). A 5 mL
culture of a single colony of in-frame PGT 4 pPICZA was grown in LBzeocin (25mg/L) at 37oC
and 250 rpm overnight. The small culture was then inoculated into 45 mL more of selective
media and grown accordingly. The 50 mL culture was harvested using a Sorvall® RC-5B
centrifuge. The BIO-RAD protocol was followed to isolate the plasmid, and 600 μL eluted DNA
was stored at -20oC.
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Figure 8. DNA and translated amino acid sequence of PGT 4 in frame with
the identification and purification tags within pPICZA. The last line shows the
His tag and stop codon confirming the correction.
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Linearization of Plasmid DNA
The Invitrogen manual recommends the use of three restriction enzymes: Sac I, Pme I, or
BstXI to linearize the pPICZA vector. These enzymes only cut the vector once. A restriction
enzyme map was made for the PGT 4 sequence to see if it contained any internal cutting sites for
any of these three enzymes. PGT 4 had an internal cutting site for Sac I. PGT 4 did not contain
internal cutting sites for Pme I or Bst XI. Either could have been used; however, BstXI was used
because it was in stock in the lab. In a sterile 1.5 mL centrifuge tube, 300 μL Midiprep DNA, 34
μL 10X Buffer D, 3 μL 100X BSA, and 3 μL BstXI were added. The reaction was placed in a
37oC water bath for four hours. After four hours, an additional 4 µL of BstXI was added to the
reaction. The digestion was continued at 37oC overnight. A 0.8% agarose gel was made to run a
sample containing: 1 μL digestion product, 4 μL distilled water, and 1 μL 6X dye. The gel
confirmed complete linearization of the plasmid DNA. Once confirmed, the sample was placed
in the 65oC water bath to stop the digestion. The digested DNA was stored at 4oC until the
phenol:chloroform extraction and ethanol precipitation could be performed.

Concentration of Linearized DNA
To concentrate the linearized DNA to sufficient amounts for electroporation, a phenol:
chloroform extraction was performed. The phenol: chloroform solvent was prepared as described
in Appendix A. First, 350 μL phenol:chloroform solvent was added to the linearized DNA in a
microfuge tube. The tube was vortexed and then centrifuged at 13,000 x g for 2 minutes. Second,
300 μL of the upper aqueous phase was extracted and transferred to a new, sterile microfuge
tube. After transfer, 30 μL of 7.5 M sodium acetate and 750 μL 100% ethanol were added to the
sample. The sample was either incubated on ice for two hours or stored at -20 oC overnight to
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precipitate the DNA. After this time, the microfuge tube was centrifuged for 10 minutes at
14,000 X g at 4oC. The supernatant was discarded, and the DNA pellet was resuspended in 1 mL
80% ethanol. The microfuge tube was centrifuged again for 10 minutes at 14,000 X g at 4oC. The
supernatant was discarded. The tube was inverted to dry for 30 minutes. For best results, the tube
was placed in a SpeedVac Concentrator (Thermo Electron Corporation) for 15 minutes. The
DNA was resuspended in sterile, distilled water, 5 to 20 μL for best results. The concentration of
DNA was determined using the NanoDrop. A 20:1 diluted sample was used to test the
concentration so as not to waste any DNA for electroporation. The linearized DNA, ready for
electroporation, was stored at -20 oC.

Yeast Harvest for Electroporation
With linearized DNA prepared for transformation, competent yeast cells were grown. An
overnight 5 mL culture of Pichia pastoris strain X33 was grown at 30oC and 250 rpm in YPD
(yeast, peptone, dextrose) media. (See Appendix B for recipe) Next, 100 μL of the yeast culture
was inoculated into 50 mL YPD media and grown overnight at 30oC and 250 rpm until reaching
the recommended OD600 of 1.3-1.5. The density was testing using a spectrophotometer against a
blank of YPD media. The optimal density was reached after approximately 13.5 hours. The yeast
cells were harvested at 4oC in a Sorvall® RC-5B super speed centrifuge (Fisher Scientific) at
1,500 X g for 5 minutes. The cells were washed with 50 mL ice cold, sterile distilled water and
centrifuged at the same rate and time. The cells were then washed with 10 mL ice cold, sterile
distilled water and centrifuged at the same rate and time after which the cells were washed with
10 mL ice cold, sterile 1 M sorbitol and centrifuged at the same rate and time. The cells were
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then resuspended in 1 mL ice cold, sterile 1 M sorbitol. The yeast cells were stored on ice until
subsequent use for electroporation.
Electroporation of PGT 4 into Yeast
Following the Invitrogen EasySelectTM Pichia manual, a 0.2 cm micro pulser cuvette
(Bio-Rad) and the sample of concentrated, linearized DNA were incubated on ice for 5 minutes.
From the yeast harvest, 80 μL of yeast cells were transferred to the linearized DNA sample and
incubated on ice for 5 minutes. The mixture was then added to the cold electroporation cuvette
and incubated on ice an additional 5 minutes. The cuvette was placed in a micropulser and
pulsed once at 1.5 kV. Immediately after the pulse, 1 mL ice cold 1M sorbitol was added to the
cuvette. The contents of the cuvette were transferred to a sterile 15 mL tube and incubated at
30oC for one hour without shaking after which the transformants were spread evenly over
YPDSzeocin (100mg/L) plates (See Appendix B for recipe) in 25, 50, 100, and 200 μL aliquots.
The plates were incubated at 28 oC for 2-3 days until colonies were observed. After initial
growth, the plates were stored at 4 oC.

PCR Screen of Yeast Transformants
To confirm transformation of PGT 4 into the yeast genome, a PCR screen using AOX1
primers was conducted. Colonies were chosen at random to test. Each chosen colony was
inoculated into 10 μL sterile, distilled water in a PCR tube. To isolate the DNA from the yeast
cells, 5 μL of 5U/ μL lyticase was added to each PCR tube. The samples were incubated at 30oC
for 10 minutes and then at -80oC for 10 minutes. The cell lysates were then thawed and used as
template for PCR. A negative control of empty pPICZA vector and a positive control of
Miniprep plasmid of PGT 4 in pPICZA were also used as control templates. In each PCR
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reaction the following was added: 5 μL 2X PCR Master Mix (See Appendix B for recipe), 0.5
μL 10 mM 5’ AOX1 primer, 0.5 μL 10 mM 3’ AOX1 primer, 3 μL sterile water, and 1 μL DNA
template. The PCR was run in a thermocycler with the following protocol (Table 8).
Table 8. Temperature Protocol for PCR with AOX1 primers
Step
1
2
3
4
5

Temperature (oC)
95
95
54
72
72

Time
5 minutes
1 minute
1 minute
1 minute
7 minutes

30 X

To confirm insertion, the 10 μL PCR products were loaded onto a 0.8% agarose gel and
run for 1 hour at 100 volts. The gel was visualized to verify positive bands corresponding to the
1467 bp PGT 4 sequence plus 300 bp of AOX1 priming sequence. Colonies found to be
positively transformed were freshly streaked on YPDSzeocin (100mg/L) plates. Also, cultures of
each positive colony were grown overnight in YPDSzeocin (100mg/L) media, saved in 50%
glycerol, and stored at -80oC.
Test Inductions for Expression of PGT 4
From each of the freshly streaked plates of positively transformed colonies, a single
colony was inoculated into 25 mL BMGY (See Appendix B for recipe) in a 250 mL baffled
flask. The culture was grown overnight at 30oC and 250 rpm to generate biomass. The culture
was grown until it reached an OD600 of 2-6 (approximately 22 hours) (Invitrogen). The yeast
cells were harvested by centrifugation in a Sorvall® RC-5B at 4oC for 5 minutes at 3,000 X g.
The cells were resuspended in 30 mL BMMY (See Appendix B for recipe) and centrifuged again
for 5 minutes at 3,000 X g. The cells were resuspended in 50 mL BMMY and transferred to
sterile 500 mL baffled flasks. Additional aliquots of BMMY were added to the cultures to reach
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an OD600 of 1. The flasks were covered with two layers of cheesecloth to allow aeration for
proper culture growth. The flasks were shaken at 30oC and 250 rpm. Every 24 hours, 100%
methanol was added to the cultures to a final concentration of 0.5% methanol to maintain
induction. Samples were taken out every six hours on the first day and every 12 hours on days 24. A 1 mL sample was taken from each culture at the following time points (hours): 0, 6,
12,24,36,48,60,72,84, and 96. Each 1 mL sample was centrifuged at 13,000 X g for 3 minutes.
The supernatant was discarded, and the cell pellet was stored at -80oC until SDS-PAGE analysis.

Preparation of Samples for SDS-PAGE Analysis
Cell pellets were thawed on ice. One hundred μL Breaking Buffer with 1% PMSF (See
Appendix B for recipe.) and an equal amount of acid-washed glass beads were added to each
sample. The samples were vortexed for thirty seconds and placed on ice for thirty seconds for
eight cycles. After lysing the cells, samples were centrifuged for 10 minutes at 14,000 x g at 4oC.
The supernatant was transferred to a new, sterile centrifuge tube. Concentrations of protein
within the samples were measured with the Nano Drop. Fifteen microliters was prepared for each
well containing 5 μL loading dye and 15 μL mixture of sample and distilled water. To
accurately analyze the amount of activity at different time intervals, an equal amount of protein
from each sample was loaded onto the protein gel. The amount of protein in15 μL of the sample
with the lowest concentration was calculated and the same amount of protein was loaded from
each sample. Distilled water was used to dilute the more concentrated samples to 15 μL. The
samples were boiled for ten minutes and centrifuged for 1 minute at 13,000 x g before loading.
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SDS-PAGE Electrophoresis
A protein electrophoresis cell from BioRad was used. Two glass plates were secured in
clamps. Ten percent separating gel and fifteen percent stacking gel solutions were mixed in
separate beakers following recipe in Appendix C. The 10% separating gel was poured by pipet
in between the glass plates until reaching 2 cm from the top and allowed to solidify for 25
minutes. To level off the top of the separating gel, 400 μL water-saturated butanol was poured
between the plates. After five minutes, the butanol was lifted off the gel using Whatman paper.
The 15% stacking gel was poured by pipet to the top of the glass plates, eliminating any bubbles
between the plates. A comb was inserted in between the plates and allowed to solidify for 25
minutes. The plates were placed within the electrophoresis cell, and 1 X TANK Buffer was
added to the middle and outer compartments (See Appendix B for recipe). The wells were loaded
with the 20 μL prepared samples using flat pipet tips. The cell was run for 15 minutes at 85V and
1.5 hours at 100V.
Staining and Destaining of Protein Gels
Protein gels were stained with Coomassie® Brilliant Blue R250 and destained with gel
destaining solution (See Appendix B for recipes). Staining solution was added to protein gels in a
dish and heated in microwave for 10 seconds, not allowing the solution to boil. The gels were
then shaken for 15 minutes. The solution was decanted, and the protein gels were rinsed with
distilled water. Destaining solution was added to the gels, and they were heated in the microwave
for 10 seconds. Gels were shaken until desirable background was achieved.
Protein gels were also silver stained according to the manufacturer’s instructions in the
Bio-Rad Silver Stain Kit. Developed gels were photographed and archived.
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Electro-blotting of SDS-PAGE
While the protein gel was running, pieces of Whatman paper (3MM CHR) and
nitrocellulose membrane were cut to the size of the protein gel. The nitrocellulose membranes
were moistened in distilled water for 5 minutes. Electro-blotting cassettes, porous pads, and filter
were moistened in a glass dish in 1 X Transfer Buffer (See Appendix B for recipe). The electroblotting cassettes were assembled as follows without air bubbles in between the layers: anode
side, porous pad, filter paper, protein gel, nitrocellulose membrane, filter paper, porous pad, and
cathode side. The cassettes were fastened and loaded into the cell. A stirrer bar gently stirred the
buffer in the cell when connected to a voltmeter at 65V for 1 hour.
Western Blot Analysis
After electro blotting, the protein gel was placed in a tray of Coomasie BrilliantBlue
G250 and gently shaken overnight to be destained later (See Appendix B for Coomasie staining
and destaining solutions). The nitrocellulose membrane was immediately placed into a tray of
blocking solution (Appendix B) and gently shaken for 2 hours. The blocking solution was poured
off, and the membrane was washed by gently shaking with 25 mL TBS with 0.02% sodium azide
for10 minutes. The wash was poured off, and the primary antibody, a monoclonal antibody cmyc from mouse, was added in a 30 mL 1:2500 solution of TBS with 0.02% sodium azide and
gently shaken for 2 hours. The primary antibody solution was poured off, and the membrane was
washed three times for 10 minutes each with 50 mL TBS without sodium azide. The membrane
was transferred to a new tray, and the secondary antibody, a goat, anti-mouse immunoglobulin G
conjugate to alkaline phosphatase (IgG-AP), was added in a 30 mL 1:10000 solution of TBS
without sodium azide and gently shaken for 2 hours. The secondary antibody was poured off and
the membrane was washed as before. The membrane was then added to a tray of developing
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solution (See Appendix B for recipe) for up to 1 minute until bands were visible. The membrane
was immediately transferred to the stop buffer (50 mL 1X TBS, 200 µL 0.5M EDTA, pH 8).
After 5 minutes in the stop buffer, the membrane was dried on a paper towel. All Western blots
were scanned and originals archived into a lab notebook.
Scale-Up Expression of PGT 4
Western blot analysis found optimum post-induction times for PGT 4. Twelve hours
post-induction was chosen due to darkness of band on Western blot and convenience of
experiment timing for purification. A scale-up of expression was conducted by growing a 100
mL yeast culture to induce with methanol for protein production. A fresh yeast colony was
inoculated into 25 mL BMGY for 18 hours at 37oC and 250 rpm until OD600 of 2-6. A 1 mL
aliquot of the 25 mL culture was inoculated into 50 mL of BMGY and grown 18 more hours at
37oC and 250 rpm to an OD600 of 2-6. The cells were harvested by centrifugation at 3,000xg and
4oC for 5 minutes. The cells were washed with 20 mL BMMY, containing methanol, and
centrifuged at 3,000xg and 4oC for 5 minutes. The cells were resuspended in BMMY, containing
methanol, to an OD600 of 1. The yeast culture was split into 2-50 mL centrifuge tubes. The cells
were harvested by centrifugation at 3,000xg and 4oC for 5 minutes. The cell pellets were saved at
-80 oC until enzyme purification and assay.
Purification and Concentration of PGT 4
Cell pellets were thawed on ice. To each pellet, 3 mL of Breaking Buffer with 1 mM
PMSF was added (See Appendix A for recipe). The suspended pellet and buffer (6 mL) was
poured into a French press (Thermo Electron Corporation). The cells were lysed three times at
2000 psi. The cell lysate was centrifuged at 13,000xg and 4 oC for 20 minutes. The supernatant
was decanted into a new test tube and stored on ice, and the cell pellet was discarded.
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A PD-10 column was equilibrated with 25 mL of Column Buffer (See Appendix A for
recipe). A 2.5 mL aliquot of cell lysate was applied to the equilibrated PD-10 column to remove
any salt from the protein. The flow through was discarded, and 3.5 mL Column Buffer was
applied to the column to elute the protein. The flow through was collected in a 50 mL centrifuge
tube and labeled PD-10 elution. Another 2.5 mL aliquot of cell lysate was desalted in the same
manner. The PD-10 was re-equilibrated with 25 mL Column Buffer to restore the column for
further use.
The protein was further purified using an immobilized metal affinity chromatography
(IMAC) column from TALON™ Resins. All purification techniques were done at 4 o C to
maintain stability of the enzyme. The histidine tag on the recombinant protein allows for
purification through metal affinity by binding the protein to the column and eluting it with
imidazole. The 4 mL bed IMAC column was equilibrated with 40 mL Column Buffer. The PD10 elution was applied slowly to the column. The flow through was collected in 2 mL centrifuge
tubes in 1 mL fractions. The IMAC column was washed with column buffer until all non-bound
proteins had been removed, leaving only tagged protein. The wash was collected in 2 mL
centrifuge tubes in 2 mL fractions. When protein concentration was below 0.1 mg/mL, Column
Buffer with 150 mM imidazole was applied to the column to elute the tagged protein. Ten each 2
mL fractions were taken and tested for protein concentration using the NanoDrop at 280 nm.
Four 2 mL elution fractions with the highest concentration of protein were added to a Amicon®
Ultra-15 and centrifuged at 4,000xg and 4oC for 10 minutes. Centrifugation was continued until
the sample was concentrated to 500 µL. To remove imidazole from the purified protein, the
concentrated sample was resuspended to a final volume of 2 mL with 50 mM phosphate buffer
with 14 mM βME (See Appendix A for recipe) and centrifuged again at the same rate and time
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until concentrated to 500 µL. The concentrated sample was resuspended to a final volume of 2
mL with 50 mM phosphate buffer with 14 mM βME and stored on ice for enzyme assay. After
enzyme assay, the enzyme was stored at 4oC for SDS-PAGE and Western blot analysis. The
IMAC column was equilibrated with 20 mL MES buffer, 20 mL milliQ water, and 25 mL 20%
ethanol with 0.1% sodium azide for storage and reuse.
Preparation of 14C-UDP-glucose and Flavonoid Substrates for Enzyme Assay
To test for enzyme activity, 14C-UDP-glucose was used as the substrate donor. A working
solution of 14C-UDP-glucose was prepared by mixing 50 µL 14C-UDP-glucose (261 mCi/ mmol)
with 950 µL 50 mM phosphate buffer to reach 20000 cpm/10µL. Various flavonoids were used
as the substrate acceptors (Table 9). A working solution of each flavonoid substrate was
dissolved into 100% ethylene glycol monomethylether to a concentration of 50nmoles/5µL and
stored at -20 oC.
Table 9. Flavonoid Substrates Screened with PGT 4 for Activity
Flavonoid subclass

Substrate Name

Naringenin

Flavanones

Hesperitin

Eriodictyol
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Substrate Structure

Isosakuranetin

Apigenin

Luteolin

Flavones

Diosmetin

Scutellerin

Flavonols

Kaempferol
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Quercetin

Fisetin

Gossypetin

4’-methoxyflavonol

Isoflavone

4’-acetoxy-7-hydroxy-6methoxy-isoflavone
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Screening of PGT 4 for Flavonoid Glucosyltransferase Activity
A total of 14 flavonoids were used as potential acceptor substrates to screen for GT
activity with PGT 4. Each test reaction was performed in duplicate with each flavonoid substrate.
A negative control using enzyme denatured with HCl were also performed in duplicate with each
flavonoid substrate. This negative control served as a background reading of activity with each
substrate. The test results were corrected against these background readings to verify positive
activity. A second negative control was conducted with quercetin using denatured PGT 4 that
had been boiled for ten minutes. A positive control using young grapefruit leaf extract as the GT
enzyme source was performed with quercetin. A second positive control combining young
grapefruit leaf extract and PGT 4 was performed to test for possible inhibiting effects of rPGT 4
on glucose incorporation.
The screening assay was adapted from McIntosh et al. (1990). For each test reaction the
following contents were added in respective order: 50 µL 50 mM phosphate buffer with 14 mM
βME, 5 µL flavonoid substrate (50 nmol), 10 µL 14C-UDP-glucose working solution (20,000
cpm), and 10 µL purified enzyme. For each negative control reaction, 15 µL 6M HCl was added
before the enzyme. The second negative control used 10 µL boiled enzyme. For the first positive
control, 60 µL young grapefruit leaf extract, suspended in 50 mM phosphate buffer with 14 mM
βME, 5 µL quercetin, and 10 µL
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C-UDP-glucose working solution was added to a reaction

tube. The young grapefruit leaf extract was prepared by crushing a young grapefruit leaf with
mortar and pestle in 2 mL 50 mM phosphate buffer with 14 mM βME and pH 7.5. For the
second positive control, 50 µL young grapefruit leaf extract, 5 µL quercetin, 10 µL 14C-UDPglucose, and 10 µL purified enzyme was loaded into a reaction tube. Each control was performed
in duplicate.
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Each reaction was incubated for 5 minutes at 37 oC. After 5 minutes, 15 µL 6M HCl was
added and vortexed for 10 seconds to stop the reaction. To separate any radiolabeled flavonoid
glucosides from unincorporated 14C-UDP-glucose, 250 µL ethyl acetate was added to the
reaction tube, vortexed for 10 seconds, and separated into organic and aqueous phases. A volume
of 100 µL was pipeted from the top organic phase and added to 2 mL scintillation fluid. The
amount of radiolabeled 14C-UDP-glucose transferred to flavonoid substrates was analyzed using
a Beckman LS 6500 scintillation counter and counts corrected to determine cpm in 250 µL of
ethyl acetate.
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RESULTS AND DISCUSSION

Confirmation of PGT 4 for Transformation
PGT 4 had been previously tested for flavonoid GT activity in E.coli. Limited substrates
were used and little activity was found. One challenge that arose was the presence of inclusion
bodies within the prokaryotic system. The inclusion bodies were found to store the induced
protein, and substantial soluble protein was not present for analysis. Thus, PGT 4 was to be
transformed into a eukaryotic system, Pichia pastoris, in order to obtain more soluble protein for
analysis.
PGT 4 glycerol stocks from Josephat Asaigo were used to confirm the sequence of PGT 4
before insertion in pPICZ A and transformation into yeast. Primers were designed based on
previous sequencing results. A previously compiled Bioedit sequence of PGT 4 was obtained
from Dr. Daniel Owens. Clone specific primers were designed based on the information from
this sequence. See Table 1 for the sequences of primers CSP 144 F and CSP 145 R. Cultures of
the glycerol stocks were made in LB media, and MiniPreps were conducted to isolate DNA
plasmid. The newly designed primers were used in a polymerase chain reaction with plasmid
DNA as template and with a TM of 64 o C to confirm the presence of the full length PGT 4
sequence within the glycerol stocks. However, PCR product was not found (Figure 9). PCR was
repeated with several different stocks with no resulting band at the expected size of full-length
PGT 4, 1467 base pairs.
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Figure 9. PCR of glycerol stocks of PGT 4. Lane M is 1 kb ladder. Lanes 2-6 are PCR product
of 5 different PGT 4 glycerol stocks. No PCR product at 1467 bp was found.
PCR was repeated with a lower TM , 59 o C. It was hypothesized that the primers could not
anneal properly to the template because their sequences were not completely conserved to that of
PGT 4. The agarose gel of the second PCR reaction had identical results. It was hypothesized
that the full length was not present within the stocks. Thus, DNA from MiniPreps of several
different glycerol stocks was sent to UTK for sequencing. The results showed that no glycerol
stock contained the full length sequence; however, each one had a partial PGT 4 clone.
Reconstruction of PGT 4
Before transformation into yeast could occur, full-length PGT 4 had to be reconstructed.
Two partial clones were found, that when digested and ligated together, could reconstruct the full
length PGT 4 sequence. The partial clones, 181.2A and 155.1A, were archived by a previous
researcher, Christy Strong. After receiving the sequencing results of these 2 partial clones, a
cloning strategy was designed. The single internal restriction site within the overlapping region
of the 2 partial clones that cut PGT 4’s sequence only once was EcoRI. However, both partial
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clones were saved within the pCR® 4-TOPO® vector, whose multiple cloning site contains
multiple sites for EcoRI (See Figure 4). With EcoRI sites on either side of the partial clone
inserts, the desired pieces of the clones could not be directly digested and ligated. A new
strategy was designed.
The partial clone sequences could be amplified out of the pCR® 4-TOPO® vector by
PCR. To PCR amplify, more clone specific primers were made (Figure 10). To be transformed
into yeast, PGT 4 was to first be cloned into the pPICZ A cloning vector. Thus, primers to
amplify the partial clones were designed with this in mind. The 5’ and 3’ end restriction enzyme
sites were chosen to be Kpn I and Not I to allow for directional cloning into the pPICZA vector
(Figure 11). The 1100 bp piece of Clone 181.2A and 300 bp piece of Clone 155.1A were to be
PCR amplified out of the pCR® 4-TOPO® vector and ligated into the pCD1 cloning vector one at
a time (Figure 12).

Figure 10. Reconstruction of PGT 4. This diagram shows the cloning strategy of the 2 partial
clones to successfully reconstruct PGT 4.
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Figure 11. Vector Map of pPICZ A. Restriction enzymes Kpn I and Not I were chosen for the 5’
and 3’ primer restriction enzyme sites, respectively. The map shows these enzymes directionally
in its multiple cloning site (Invitrogen).

Figure 12. This pCD1 vector map shows the restriction cloning sites directionally (5’ to 3’).
This vector was a gift from Brenda Winkel of Virginia Tech. The restriction enzymes chosen
digest pCD1 a single time. The partial clones were inserted directionally one at a time.
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PCR Amplification of 181.2A piece
The strategy to PCR amplify the partial clones out of the pCR® 4-TOPO® vector and
directionally clone the pieces into the pCD1 vector was successful. To reconstruct PGT 4, Clone
181.2A was amplified by PCR with clone specific primers, CSP 144F and CSP 149R. See Table
2 for details. Figure 13 shows the 1100 bp piece of Clone 181.2A that was PCR amplified from
MiniPrep DNA of Clone 181.2A.
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Figure 13. PCR Amplification of 181.2A piece. Lane M is the 1 kb ladder. Lane 1 is pCD1
vector MiniPrep DNA. Lanes 2-5 are PCR products with CSP 144F and CSP 149R. The band
around 1100 bp suggests the desired 181.2A piece.

The 181.2A bands at around 1100 bp were extracted and gel purified. Multiple bands
were excised and purified to obtain a good DNA concentration for digestion. The purified DNA
was used for digestion with KpnI and EcoRI. The pCD1 vector was also digested with Kpn I and
EcoRI in order for the insert and vector to be ligated together (Figure 14).
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Figure 14. Digestion of 181.2A piece and pCD1 vector. M represents 1 kb ladder. A. Lanes 13 are 181.2A digestion with KpnI and EcoRI. B. Lanes 1-4 are pCD1 vector digested with KpnI
and EcoRI. All wells were loaded with 15 µL from digestion and 3 µL 6x loading dye. Bands
were excised and gel purified for ligation.
Ligation and Transformation of 181.2A into pCD1
The digested 181.2A piece bands and the digested pCD1 bands were extracted and gel
purified. The digested DNA of the insert and the vector were ligated together. The ligated
product was transformed into OneShot® Top 10 Cells. Colonies were grown on selective LB
plates with ampicillin (100 mg/L). Four transformant colonies grew overnight on the plates at
37oC. A PCR screening was conducted with CSP 144F and CSP 149R to verify the presence of
the 181.2A piece within the pCD1 vector. The ligation ratio of 3:1 insert:vector resulted in
colonies which successfully included the 181.2A insert. Two colonies showed a positive band at
1100 bp, suggesting the 181.2A piece was successfully ligated in the vector (Figure 15).
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Figure 15. PCR Screen for Confirmation of 181.2A Ligation. M represents 1 kb ladder.
Lanes 1-4 are PCR product from transformed colonies. The band around 1100 bp indicates the
presence of the 181.2A piece within pCD1.
The colonies containing the insert, Colonies 3 and 4 were inoculated into LB media with
ampicillin (100 mg/L). DNA plasmid was isolated to send for sequencing. Once the sequence
was confirmed, more DNA plasmid was isolated to insert the second partial clone, 155.1A.
PCR Amplification of 155.1A
Clone specific primers were designed to amplify 155.1A out of the pCR® 4-TOPO®
vector. CSP 150F and CSP 151R were used in the PCR reaction (See Table 2 for details). The
PCR products showed a band around 300-400 bp, the desired size of the 155.1A piece (Figure
16).
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Figure 16. PCR Amplification of 155.1A piece. M is 1 kb ladder. Lanes 1-5 are PCR product
of 155.1A piece. Bands were excised, gel purified, digested with EcoRI and NotI and ligated into
pCD1.
These five bands were excised and gel purified for digestion. To reconstruct PGT 4
directionally, the pCD1 vector with the 181.2A insert and the 155.1A piece were both digested
with EcoRI and NotI. Figure 17 shows an agarose gel of a digestion of pCD1 + 181.2A piece
and of 155.1A piece. The 155.1A piece bands were extracted and gel purified. The pCD1 +
181.2A piece digestion was not successful and was repeated, Figure 18. The bands were
extracted and gel purified for ligation.
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Figure 17. Digestion of pCD1 vector and 155.1A piece. M is 1 kb ladder. Lanes 1-2 are pCD1
digested with EcoRI and NotI. Lanes 3-5 are 155.1A piece digested with EcoRI and NotI.
Digestion of pCD1 was repeated for proper bands. Bands from Lanes 3-5 were used for ligation.
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Figure 18. Repeated digestion of pCD1. M is 1 kb ladder. Lanes 1-3 are pCD1 digested with
EcoRI and NotI. Bands were excised and gel purified for ligation.

Ligation and Transformation of 155.1A piece into pCD1 + 181.2A piece
The DNA from gel purification was used to set up a ligation. The ligation product was
transformed into OneShot® Top 10 Cells. Colonies were grown on selective LB plates with
ampicillin (100 mg/L). Nine transformant colonies grew overnight on the plates at 37oC. A PCR
screening was conducted with CSP 144F and CSP 151R to verify the presence of the 155.1A
piece within the pCD1 vector. One colony showed a positive band at around 1500 bp, suggesting
the 155.1A piece was successfully ligated in the vector. This band suggests the full length
reconstruction of PGT 4 (Figure 19).
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Figure 19. PCR Confirmation of PGT 4 Reconstruction. M is 1 kb ladder. Lanes 1-11 are
PCR product from each respective colony found on selective plates after transformation. Colony
4 shows a band at 1500 bp suggesting presence of full length PGT in plasmid DNA.
The colony containing full length PGT 4, Colony 5, was inoculated into LB media with
ampicillin (100 mg/L). DNA plasmid was isolated to send for sequencing. The sequencing
results confirmed the successful reconstruction of PGT 4 (Figure 20).

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
510
520
530
540
550
---------- ---------- ATGGCATCCG AAGCCAGCCA GGTTCACTTT
ACAGCCCAGA TCTGGGTACC ATGGCATCCG AAGCCAGCCA GGTTCACTTT

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
560
570
580
590
600
CTCTTGCTTC CTTACTTGGC TCCAGGCCAC TTGATTCCCA TGTTTGACAT
CTCTTGCTTC CTTACTTGGC TCCAGGCCAC TTGATTCCCA TGTTTGACAT

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
610
620
630
640
650
TGCTAGATTG CTTGCACAGC ATGGAGCTAT TGTTACTATT GTCACCACCC
TGCTAGATTG CTTGCACAGC ATGGAGCTAT TGTTACTATT GTCACCACCC

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
660
670
680
690
700
CAGTTAATGT GGCAAGGTTC AAAACAGTGA TTGCTCGTGC AATAAAATCC
CAGTTAATGT GGCAAGGTTC AAAACAGTGA TTGCTCGTGC AATAAAATCC

57

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
710
720
730
740
750
GGCCTACAAA TCCGACTAAT TGAGATCCAG TTTCCTTGGC AAGAAGCAGG
GGCCTACAAA TCCGACTAAT TGAGATCCAG TTTCCTTGGC AAGAAGCAGG

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
760
770
780
790
800
AATACCTGAA GGTTGTGAGA ATTGTGACTT GCTTCCTACA ACAGACTTTG
AATACCTGAA GGTTGTGAGA ATTGTGACTT GCTTCCTACA ACAGACTTTG

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
810
820
830
840
850
CAAGGTTCAT GAAGTCGCTT CACATGCTTC AACAGCCTTT TGAAAATTTG
CAAGGTTCAT GAAGTCGCTT CACATGCTTC AACAGCCTTT TGAAAATTTG

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
860
870
880
890
900
TTCAAAGAGA AAACTCTTAA GCCCTGCTGC ATAATCTCTG ACATGTGTTT
TTCAAAGAGA AAACTCTTAA GCCCTGCTGC ATAATCTCTG ACATGTGTTT

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
910
920
930
940
950
TCCTTGGACG GTGGATACAG CTGCCAAGTT CAATGTTCCA AGGATTATTT
TCCTTGGACG GTGGATACAG CTGCCAAGTT CAATGTTCCA AGGATTATTT

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
960
970
980
990
1000
TCCATGGATT TTCTTGCTTC TGTCTCTTCT GTCATCACCT CTTGGG-TGT
TCCATGGATT TTCTTGCTTC TGTCTCTTCT GTCATCACCT CTTGGGGTGT

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
1010
1020
1030
1040
1050
TTCAAAGGTT CACGAGAATG TTACTTCTGA TTCAGAGTAC TTTAATATAC
TTCAAAGGTT CACGAGAATG TTACTTCTGA TTCAGAGTAC TTTAATATAC

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
1060
1070
1080
1090
1100
CAAGTATTGA TATTATCACA CCCTGCAGTC GGAGGGTTCT TAACGCATTG
CAAGTATTGA TATTATCACA CCCTGCAGTC GGAGGGTTCT TAACGCATTG

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
1110
1120
1130
1140
1150
CGGCTGGAAT TCATCTCTGG AAGGGATATC AGCTGGGGTT CAAATGCTTA
CGGCTGGAAT TCATCTCTGG AAGGGATATC AGCTGGGGTT CAAATGCTTA
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PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
1160
1170
1180
1190
1200
CATGGCCACT CTTTGCAGAC CAATTTTGCA ATGAGAAGTT GATTGTGAAT
CATGGCCACT CTTTGCAGAC CAATTTTGCA ATGAGAAGTT GATTGTGAAT

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
1210
1220
1230
1240
1250
GTTTTAAGGA TTGGTGTGAG TGTTGGAGTG GAAGTTCCAA TGAATTTTGG
GTTTTAAGGA TTGGTGTGAG TGTTGGAGTG GAAGTTCCAA TGAATTTTGG

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
1260
1270
1280
1290
1300
AGAAGAAGAG AAGATTGGAG TATTGGTGAA TAAGGAAAAT GTCAAAACGG
AGAAGAAGAG AAGATTGGAG TATTGGTGAA TAAGGAAAAT GTCAAAACGG

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
1310
1320
1330
1340
1350
CTATAAACAT ACTGATGGAT GATGGAGAGG AAAGAAATGC GAGAAGAAGT
CTATAAACAT ACTGATGGAT GATGGAGAGG AAAGAAATGC GAGAAGAAGT

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
1360
1370
1380
1390
1400
GCCAGAGAGT TTGGAGAGTT GGCTAAAAGA GCTATAGATG AAGGTGGATC
GCCAGAGAGT TTGGAGAGTT GGCTAAAAGA GCTATAGATG AAGGTGGATC

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
1410
1420
1430
1440
1450
TTCCTATAAC AACGTCGAAT TATTTATGCA AGATATCATG CAACAGCCGA
TTCCTATAAC AACGTCGAAT TATTTATGCA AGATATCATG CAACAGCCGA

PGT 4
sequencing

....|....| ....|....| ....|....| ....|....| ....|....|
1460
1470
1480
1490
1500
GCTCAGAAGT GATTTAA--- ---------- ---------- ---------GCTCAGAAGC GATTGCGGCC GCACTCGAGC ACCACCACCA CCACCACTGA

Figure 20. Sequencing Results Confirming Reconstruction of Full-Length PGT 4

Cloning into pPICZ A
When designing primers to amplify the partial clones, restriction enzymes were chosen
that existed directionally within the pPICZ A multiple cloning site (Figure 11). To clone PGT 4
into the pPICZ A vector, full-length PGT 4 in pCD1 and empty pPICZ A vector were both
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digested with KpnI and NotI. Figure 21 shows both digestions. The bands were excised and gel
purified. The purified DNA was used for a ligation.
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Figure 21. Digestion of pPICZ A vector and PGT 4 in pCD1. M is 1 kb ladder. Lanes 1-2 are
pPICZ A vector digested with KpnI and NotI. Lanes 3-5 are PGT 4 in pCD1 digested with KpnI
and NotI. Bands from Lanes 1-2 and bands at 1500 bp from Lanes 3-5 were excised, gel purified,
and used for ligation.
The ligation product was transformed into OneShot® Top 10 Cells. Colonies were grown
on selective LB plates with zeocin (25 mg/L). Twelve transformant colonies grew overnight on
the plates at 37oC. A PCR screening was conducted with CSP 144F and CSP 151R to verify the
presence of the PGT 4 within the pPICZ A vector. Five colonies showed a positive band at
around 1500 bp, suggesting PGT 4 was successfully ligated in the pPICZ A vector (Figure 22).
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Figure 22. PCR Screening of Transformed ligated pPICZ A and PGT 4. M is 1 kb ladder.
Lanes 1-13 are PCR product from respective colonies. Lane 13 is a positive control. Lane 14 is a
negative control. Colonies 2,3, 8, 9 and 10 showed bands at 1500 bp suggesting presence of PGT
4 within plasmid DNA.
The colonies containing full length PGT 4, Colonies 2,3,8,9, and 10, were inoculated into
LB media with zeocin (25 mg/L). The isolated DNA plasmid was sent for sequencing. The
sequencing results confirmed the successful insertion of PGT 4 into the pPICZ A vector (Figure
23).

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
60
70
80
90
100
---------- ---------- ---------- ---------- ----ATGGCA
ACGAGGAATT CACGTGGCCC AGCCGGCCGT CTCGGATCGG TACCATGGCA
---------- ---------- ---------- ---------- ----------

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
110
120
130
140
150
TCCGAAGCCA GCCAGGTTCA CTTTCTCTTG CTTCCTTACT TGGCTCCAGG
TCCGAAGCCA GCCAGGTTCA CTTTCTCTTG CTTCCTTACT TGGCTCCAGG
---------- ---------- ---------- ---------- ----------

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
160
170
180
190
200
CCACTTGATT CCCATGTTTG ACATTGCTAG ATTGCTTGCA CAGCATGGAG
CCACTTGATT CCCATGTTTG ACATTGCTAG ATTGCTTGCA CAGCATGGAG
---------- ---------- ---------- ---------- ----------
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PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
210
220
230
240
250
CTATTGTTAC TATTGTCACC ACCCCAGTTA ATGTGGCAAG GTTCAAAACA
CTATTGTTAC TATTGTCACC ACCCCAGTTA ATGTGGCAAG GTTCAAAACA
---------- ---------- ---------- ---------- ----------

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
260
270
280
290
300
GTGATTGCTC GTGCAATAAA ATCCGGCCTA CAAATCCGAC TAATTGAGAT
GTGATTGCTC GTGCAATAAA ATCCGGCCTA CAAATCCGAC TAATTGAGAT
---------- ---------- ---------- ---------- ----------

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
310
320
330
340
350
CCAGTTTCCT TGGCAAGAAG CAGGAATACC TGAAGGTTGT GAGAATTGTG
CCAGTTTCCT TGGCAAGAAG CAGGAATACC TGAAGGTTGT GAGAATTGTG
---------- ---------- ---------- ---------- ----------

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
360
370
380
390
400
ACTTGCTTCC TACAACAGAC TTTGCAAGGT TCATGAAGTC GCTTCACATG
ACTTGCTTCC TACAACAGAC TTTGCAAGGT TCATGAAGTC GCTTCACATG
---------- ---------- ---------- ---------- ----------

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
410
420
430
440
450
CTTCAACAGC CTTTTGAAAA TTTGTTCAAA GAGAAAACTC TTAAGCCCTG
CTTCAACAGC CTTTTGAAAA TTTGTTCAAA GAGAAAACTC TTAAGCCCTG
---------- ---------- ---------- ---------- ----------

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
460
470
480
490
500
CTGCATAATC TCTGACATGT GTTTTCCTTG GACGG-TGGA TACAGCTGCC
CTGCATAATC TCTGACATGT GTTTTCCTTG GACGG-TGGA TACAGCTGCC
---------- --TGGTGT-- -TTTTCCTTG AACSGATGAA TACAG-TGCA

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
510
520
530
540
550
AAGTTCAATG TTCCAAGGAT TATTTTCCAT GGATTTTCTT GCTTCTGTCT
AAGTTCAATG TTCCAAGGAT TATTTTCCAT GGATTTTCTT GCTTCTGTCT
G---TCAATG TACAGA---- --TATTTCAT GAATTT---- -CTGCTCGTT

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
560
570
580
590
600
CTTCTGTCAT CACCTCTTGG GTGTTTCAAA GGTTCACGAG AATGTTACTT
CTTCTGTCAT CACCTCTTGG GTGTTTCAAA GGTTCACGAG AATGTTACTT
CTCTCGTCAT CACT--CTGG GTGTTCAAG- ---TCACGAG AATGT-ACTT
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PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
610
620
630
640
650
CTGATTCAGA GTACTTTAAT ATACCTGGAT TGCCTGATCA CATTCAATTT
CTGATTCAGA GTACTTTAAT ATACCTGGAT TGCCTGATCA CATTCAATTT
CGA--TCAGA GTACTT-AAT ATAC-TGGAT --GCTGATCA CAT-CAATTT

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
660
670
680
690
700
ACTAAAGTTC AATTACTAAT ATCCAAGCGG GATGATGACC GTAAAGAGCT
ACTAAAGTTC AATTACTAAT ATCCAAGCGG GATGATGACC GTAAAGAGCT
ACTAAAGTCA A--TACTAAT ATC-AAGCGG -ATGATGAC- GTAAAGAGCT

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
710
720
730
740
750
TCGAGAGCAA ATTTTGGCGG CCGATAAGAA AACATACGGC GCGATTATAA
TCGAGAGCAA ATTTTGGCGG CCGATAAGAA AACATACGGC GCGATTATAA
-CGAGAGCAA ATTT-GGCGG CCGATAAGAA AACATACGGC GCGATTATAA

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
760
770
780
790
800
ATACCTTCGA AGAGCTAGAG TCGCCATTTA TTGAAAACTA CAAAAAAGCC
ATACCTTCGA AGAGCTAGAG TCGCCATTTA TTGAAAACTA CAAAAAAGCC
ATAC-TTCGA AGAGCTAGAG TCGCCATTTA TTGAAAACTA CAAAAAAGCC

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
810
820
830
840
850
AAACAAGGAA AAGTTTGGCG CATCGGCCCT GCTTCGCTGT GCAACAAAGA
AAACAAGGAA AAGTTTGGCG CATCGGCCCT GCTTCGCTGT GCAACAAAGA
AAACAAGGAA AAGTTTGGCG CATCGGCC-T GCTTCGCTGT GCAACAAAGA

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
860
870
880
890
900
GCCCATAGAC AAGGCAGAGA GAGGTAGAAC AGCATCAATT GATGTTCCTG
GCCCATAGAC AAGGCAGAGA GAGGTAGAAC AGCATCAATT GATGTTCCTG
GCCCATAGAC AAGGCAGAGA GAGGTAGAAC AGCATCAATT GATGTTC-TG

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
910
920
930
940
950
AATGCTTAAC ATGGCTTGAT TCACAGCAGC CAAGCTCAGT AGTCTATGTT
AATGCTTAAC ATGGCTTGAT TCACAGCAGC CAAGCTCAGT AGTCTATGTT
AATGCTTAAC ATGGCTTGAT TCACAGCAGC CAAGCTCAGT AGTCTATGTT

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
960
970
980
990
1000
TGTCTTGGAA GCATCTGTAA CTTGCCATCT TCACAACTTA TAGAGCTCGG
TGTCTTGGAA GCATCTGTAA CTTGCCATCT TCACAACTTA TAGAGCTCGG
TGTCTTGGAA GCATCTGTAA CTTGCCATCT TCACAACTTA TAGAGCTCGG
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PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
1010
1020
1030
1040
1050
TTTAGGCCTT GAAGCATCTA ACAAACCGTT TGTTTGGGTT ATCAGGGGAG
TTTAG-CCTT GAAGCATCTA ACAA-CCGTT TGTT-GGGTT ATCAGGG-AG
TTTAGGCCTT GAAGCATCTA ACAAACCGTT TGTTTGGGTT ATCAGGGGAG

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
1060
1070
1080
1090
1100
TGAGTAAATT AGAAGCATTA GAGAAGTGGC TTGTACAAGA AAATTTTGAA
TGAGTAA-TT AGA-GCATTA GAGAAGTGGC TTGTACAAGA AAATTTTGAA
TGAGTAAATT AGAAGCATTA GAGAAGTGGC TTGTACAAGA AAATTTTGAA

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
1110
1120
1130
1140
1150
GAAAGGATTA AAGGAAGAGG CCTTTTGATT CGGGGTTGGG CACCACAAGT
GAT--GATT- ----AAGAGA GCTTTTGGAT CG----CTGG CAC-ACAAGT
GAAAGGATTA AAGGAAGAGG CCTTTTGATT CGGGGTTGGG CACCACAAGT

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
1160
1170
1180
1190
1200
ATTGATATTA TCACACCCTG CAGTCGGAGG GTTCTTAACG CATTGCGGCT
AT-GATATTA TCACACC-TG CAGTCGAAG- ----TCTACG CAT-GCG--C
ATTGATATTA TCACACCCTG CAGTCGGAGG GTTCTTAACG CATTGCGGCT

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
1210
1220
1230
1240
1250
GGAATTCATC TCT-GGAAGG GATAT--CAG CTGGGGTTCA AATGCTTACA
TGTATTCATC TCTTGGAAAG GATAWTCCAG CCTGGGGGG- ---------GGAATTCATC TCT-GGAAGG GATAT--CAG CTGGGGTTCA AATGCTTACA

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
1260
1270
1280
1290
1300
TGGCCACTCT TTGCAGACCA ATTTTGCAAT GAGAAGTTGA TTGTGAATGT
---------- ---------- ---------- ---------- ---------TGGCCACTCT TTGCAGACCA ATTTTGCAAT GAGAAGTTGA TTGTGAATGT

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
1310
1320
1330
1340
1350
TTTAAGGATT GGTGTGAGTG TTGGAGTGGA AGTTCCAATG AATTTTGGAG
---------- ---------- ---------- ---------- ---------TTTAAGGATT GGTGTGAGTG TTGGAGTGGA AGTTCCAATG AATTTTGGAG

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
1360
1370
1380
1390
1400
AAGAAGAGAA GATTGGAGTA TTGGTGAATA AGGAAAATGT CAAAACGGCT
---------- ---------- ---------- ---------- ---------AAGAAGAGAA GATTGGAGTA TTGGTGAATA AGGAAAATGT CAAAACGGCT
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PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
1410
1420
1430
1440
1450
ATAAACATAC TGATGGATGA TGGAGAGGAA AGAAATGCGA GAAGAAGTGC
---------- ---------- ---------- ---------- ---------ATAAACATAC TGATGGATGA TGGAGAGGAA AGAAATGCGA GAAGAAGTGC

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
1460
1470
1480
1490
1500
CAGAGAGTTT GGAGAGTTGG CTAAAAGAGC TATAGATGAA GGTGGATCTT
---------- ---------- ---------- ---------- ---------CAGAGAGTTT GGAGAGTTGG CTAAAAGAGC TATAGATGAA GGTGGATCTT

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
1510
1520
1530
1540
1550
CCTATAACAA CGTCGAATTA TTTATGCAAG ATATCATGCA ACAGCCGAGC
---------- ---------- ---------- ---------- ---------CCTATAACAA CGTCGAATTA TTTATGCAAG ATATCATGCA ACAGCCGAGC

PGT 4
5' C5
3' C5

....|....| ....|....| ....|....| ....|....| ....|....|
1560
1570
1580
1590
1600
TCAGAAGTGA TTTAA----- ---------- ---------- ------------------- ---------- ---------- ---------- ---------TCAGAAGTGA TTGGCGGCCG CCAGCTTGGG CCCGAACAAA AACTCATCTC

Figure 23. Sequencing Results Confirming Insertion of PGT 4 into the pPICZ A vector
Frame shifting PGT 4 in pPICZ A
Upon alignment of the PGT 4 sequencing results, it was found that the c-myc epitope and
histidine tags on the 5’ end of the pPICZ A vector, immediately following the PGT 4 sequence,
were out-of-frame. These tags are essential for identification and purification of the enzyme.
Without these tags in frame, the presence of PGT 4 would not be visible on a Western blot. Thus,
the frame shift was studied. It was found that only one base pair needed to be added to the 3’
primer to successfully frame shift the sequence. The challenge arose because the 3’ primer base
pair length was not a multiple of three. This fact led to a frame shift of the tags which were
designed with specific amino acid codon sequences which are in multiples of three. See Figure 7
for more details.
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A new 3’ end primer, CSP 164R was designed inserting one guanine base pair to the
primer sequence. A new 5’ end primer, CSP 163F, was designed to more closely match the
melting temperature of the new primer sequence to ensure proper annealing and amplification by
PCR. Amplification by PCR resulted in a desired band of around 1500 bp (Figure 24). PCR
product was rapidly cloned into the pCR® 4-TOPO® vector, digested with KpnI and NotI, and
ligated into pPICZ A vector also digested with KpnI and NotI.
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Figure 24. Digestion of pPICZ A vector and PGT 4 in pCR® 4-TOPO®. M is 1 kb ladder.
Lanes 1-2 are pPICZ A vector digested with KpnI and NotI. Lanes 3-4 are PGT 4 in pCR® 4TOPO® digested with KpnI and NotI. Bands from Lanes 1-2 and bands at 1500 bp from Lanes 34 were excised, gel purified, and used for ligation.
The ligation product was transformed into OneShot® Top 10 Cells. Colonies were grown
on selective LB plates with zeocin (25 mg/L). Several transformant colonies grew overnight on
the plates at 37oC. Seventeen colonies were chosen at random for PCR screening. A PCR
screening was conducted with CSP 163F and CSP 164R to verify the presence of the PGT 4
within the pPICZ A vector. Colonies 5 and 13 showed a very light positive band at around 1500
bp, suggesting PGT 4 was successfully ligated in the pPICZ A vector (Figure 25).
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Figure 25. PCR Screening of Transformed ligated pPICZ A and PGT 4. M is 1 kb ladder.
Lanes 1-13 are PCR product from respective colonies. Lane 19 is a positive control. Colonies 5
and 13 showed faint bands at 1500 bp suggesting presence of PGT 4 within plasmid DNA.
The colonies containing full length PGT 4, Colonies 5 and 13, were inoculated into LB
media with zeocin (25 mg/L). DNA plasmid was isolated and sent for sequencing. The
sequencing results confirmed the insertion of PGT 4 into the pPICZ A vector with the c-myc
epitope and histidine tags in frame (Figure 26).
c-myc epitope tag

histidine tag

Figure 26. Frameshift of pPICZ A tags for identification and purification. PGT 4
sequencing results of Colonies 5 and 13 showed tags in frame allowing for identification and
purification when transformed into yeast (Invitrogen).
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Transformation of PGT 4 into Pichia pastoris
X-33 strain yeast cells were grown in YPD media and harvested for electroporation.
pPICZ A vector storing the PGT 4 sequence was linearized with BstXI for electroporation. The
Invitrogen manual suggests the use of SacI, BstXI, and PmeI. A restriction map of the PGT 4
sequence revealing an internal cutting site of SacI. Thus, BstXI or PmeI had to be used. BstXI
was chosen due to its availability in lab stocks. Isolation of plasmid was conducted via MidiPrep,
and DNA was digested overnight with BstXI. To confirm complete linearization, a 2 μL sample
from the digestion was run on an agarose gel. The results confirmed the complete digestion.
(Figure 27).
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Figure 27. Linearization of PGT 4 in pPICZ A with BstXI. M is 1 kb ladder. Lane 1 is PGT 4
in pPICZA DNA plasmid. Lane 2 is sample from overnight digestion of PGT 4 in pPICZ A with
BstXI. Absence of lines in lane confirms complete digestion of DNA ready for concentration.
The digested DNA was concentrated by the processes of phenol: chloroform extraction
and ethanol precipitation. The DNA was resuspended in 20 μL distilled water for
electroporation. Electroporation with concentrated DNA and yeast cells was conducted as
described and sampled were spread on selective YPDS plates (zeocin 100 mg/L). After
incubation for three days, six colonies were found and PCR screened with CSP 163F and CSP
164R to verify the presence of the PGT 4 within the yeast genome (Figure 28).
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Figure 28. PCR Screening of Transformants of Electroporation I. M is 1 kb ladder. Lanes 16 are PCR product from respective colonies with CSP 163F and CSP 164R. Lane 7 is positive
control. Lack of bands suggests absence of PGT 4 in yeast genome of Colonies 1-6.
When the presence of PGT 4 was not found, it was hypothesized that the yeast cells were
not properly lysed when isolating DNA for PCR amplification. Presence of the colonies on the
selective plate indicated that the colonies should contain the pPICZ A vector sequence with
zeocin resistance. Cell lysing and PCR screens were repeated several times with identical results.
A second electroporation with new linearized DNA and yeast cells was conducted. PCR
screening of nine transformed colonies still found no presence of PGT 4 in the yeast genome
(Figure 29).
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Figure 29. PCR Screening of Transformants of Electroporation II. M is 1 kb ladder. Lanes
1-10 are PCR product of respective colonies with AOX1 primers. Lane 11 is a positive control.
Lane 12 is a negative control. Lack of bands suggests absence of PGT 4 in yeast genome of
Colonies 1-10.
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Possible solutions to optimize transformation success were studied. The Invitrogen
manual recommends electroporation with 1µg/µL and to use 5-10 µL. In previous
electroporations, the recommended amount of DNA was used but not within the recommended
volume due to insufficient drying after ethanol precipitation. To increase concentration of
linearized DNA, a Speed Vac Concentrator (Thermo Electron Corporation) for fifteen minutes.
This process allowed all remaining ethanol to be evaporated and the DNA pellet was
resuspended in 5 µL.
A third electroporation was conducted preparing the linearized DNA as described. The
transformation product was plates on selective YPDS plates (zeocin 100mg/L). After incubation
at 28oC for three days, eleven colonies were found and screened by PCR for the presence of PGT
4. Three colonies showed PCR product just above 1500 bp. These bands were the desired length
representing the 1467 bp PGT 4 sequence and the 300 bp AOX1 priming site sequence (Figure
30).
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Figure 30. PCR Screening of Transformants of Electroporation III. M is 1 kb ladder. Lanes
1-11 are PCR product of respective colonies with AOX1 primers. Lane 12 is a positive control.
Lane 13 is a negative control. Bands around 1500 bp suggest presence of PGT 4 in yeast genome
of Colonies 7-9.

70

These bands confirmed the sequence of PGT 4 within the yeast genome in Colonies 7, 8,
and 9. These yeast colonies were restreaked on fresh YPD plates, grown at 28oC for 2 days, and
saved at 4oC.
Western Blot Analysis of Test Inductions
Test inductions of Colonies 7, 8, and 9 were conducted. Samples were taken at
0,6,12,24,36,48,60,72,84, and 96 hours. Cell pellets were saved at -80oC for SDS-PAGE and
Western Blot analysis.
Samples were lysed and resuspended in Breaking Buffer (Appendix A). Protein aliquots
from all samples were used for SDS-PAGE, electro-blotted onto a nitrocellulose membrane, and
shaken with appropriate antibodies for Western blot analysis. Development of the Western blot
showed protein production was optimum at 6-12 hours post-induction. Figure 31 shows the
Western blots of all test induction samples of each colony.
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Figure 31. Western Blot Analysis of Test Inductions. A. Bands were found around 54 kD, the
hypothesized protein size of PGT 4. The heaviest bands occur at 6 and 12 hours suggesting
optimum protein production post-induction. B. Lighter bands found at later times post-induction.
Results suggest longer incubation time decreases protein production.
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On the two Western blots, bands were found around 54 kD, the hypothesized protein size
of PGT 4. The darkest bands occurred at 6 and 12 hours suggesting optimum protein production
post-induction. Much lighter bands were found at later times post-induction. These results
suggest a longer incubation time decreases protein production.

Purification of PGT 4
To test for specific protein function, PGT 4 was isolated from all other proteins produced
within yeast. The C-terminal His-tag within the pPICZ A vector allowed PGT 4 to be purified
using metal affinity chromatography for purification. Yeast cells were grown to optimum postinduction time of 12 hours and harvested. The cell pellet was resuspended in Breaking Buffer
with βME to prevent the formation of disulfide bridges and PMSF to prevent protease activity in
the protein. The cells were lysed by French press, and the cell lysate was centrifuged. The
supernatant was desalted with a PD-10 column to remove any salt that could interfere with
binding to the metal affinity column. The desalted elution was subsequently applied to an IMAC
column, and fractions were saved at 4oC to be analyzed by SDS-PAGE, Silver Staining, and
Western blot. The Silver Staining shows three dark lanes which are the washes from the IMAC
column eluting protein without a His tag. The next four lanes show the elutions of tagged PGT 4
which were concentrated for enzyme assay. The product of the concentration, the purified
enzyme, is shown in the last lane (Figure 32). The Western Blot shows the lack of tagged
enzyme in the washes, the tagged enzyme in the elutions, and the final purified enzyme used for
assay (Figure 33). The final concentration of purified enzyme used for assay was 0.91 mg/mL.
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Figure 32. Silver Stain of IMAC Purification for PGT 4 Screening. M represents low range
protein ladder. W1-3 represent wash fractions collected from IMAC column. The bands
represent all proteins washed away to purify PGT 4. E1-4 signify elutions from IMAC after
addition of imidazole. These four fractions were concentrated for protein analysis. PE represents
purified PGT 4 used for enzyme screening.
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Figure 33. Western Blot of IMAC Purification for PGT 4 Screening. M represents low range
protein ladder. W1-3 represent wash fractions collected from IMAC column. The bands
represent all proteins washed away to purify PGT 4. E1-4 signify elutions from IMAC after
addition of imidazole. These four fractions were concentrated for protein analysis. PE represents
purified PGT 4 used for enzyme screening.
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Screening of PGT 4 for Flavonoid Glucosyltransferase Activity
A total of 14 flavonoids were used as potential acceptor substrates to screen for GT
activity with PGT 4. Each test reaction was performed in duplicate with each flavonoid substrate.
A negative control using enzyme denatured with HCl were also performed in duplicate with each
flavonoid substrate. This negative control served as a background reading of activity with each
substrate. The test results were corrected against these background readings to verify positive
activity. A second negative control was conducted using denatured PGT 4 that had been boiled
for ten minutes with quercetin. A positive control using young grapefruit leaf extract as the GT
enzyme source was performed with quercetin. A second positive control combining young
grapefruit leaf extract and PGT 4 was performed to test for inhibiting effects of glucose
incorporation. The amount of radiolabeled 14C-UDP-glucose transferred to flavonoid substrates
was analyzed using a Beckman LS 6500 scintillation counter to determine cpm in 250 µL.
Results show the average cpm incorporation of the substrates tested with PGT 4 (Table 10).
Table 10. Screening of PGT 4 for Flavonoid Glucosyltransferase Activity
(Note: 20000 cpm 14C-UDP-glucose was used per reaction)
Substrate Name

Flavanones

Substrate Structure

Average cpm
incorporation
(n=2, 250 µL
ethyl acetate)

Naringenin

n.a.

Hesperitin

10

Eriodictyol

n.a.
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Isosakuranetin

n.a.

Apigenin

n.a.

Luteolin

n.a.

Diosmetin

15

Scutellerin

n.a.

Kaempferol

n.a.

Quercetin

n.a.

Fisetin

26

Gossypetin

n.a.

Flavones

Flavonols

76

4’methoxyflavonol

Isoflavone

Controls

n.a.

4’-acetoxy-7hydroxy-6methoxyisoflavone
Positive
Negative

2

Young grapefruit leaf extract + Quercetin
Young grapefruit leaf extract + PGT 4 +
Quercetin
Denatured PGT 4 + Quercetin

914
1645
73

According to these results, no significant GT activity was found with PGT 4. All tests
were conducted in duplicate, and the results were corrected against duplicate background
controls and for 250 μL ethyl acetate. The positive control with crude extract showed activity as
several GTs are found within young grapefruit leaf tissue. The second positive control, using
crude extract and purified enzyme, showed increased activity levels compared to the crude
extract. This result could suggest that PGT 4’s preferred substrate acceptor is found within the
crude extract. Also, this finding could be explained by PGT 4 being a part of a multi-enzyme
complex. The increased activity of the control could be a result of PGT 4’s interaction with other
necessary enzymes to exhibit glucosyltransferase activity.
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SUMMARY and FUTURE WORK
PGT 4 was successfully reconstructed to its full-length of 1467 base pairs. The c-myc
epitope and histidine tags were shifted into frame allowing for identification and purification of
PGT 4 for flavonoid GT analysis. PGT 4 was found to have predicted size of around 54 kD.
Optimum post-induction time was determined to be 12 hours by Western blot analysis. SDSPAGE, Silver staining, and Western blot analysis were conducted to ensure presence of purified
protein. PGT 4 was screened against 14 flavonoid substrates for flavonoid glucosyltransferase
activity. No significant GT activity was found with PGT 4. Repeats of the screening with these
flavonoids and the controls could be done to ensure accurate results. If the results of the positive
controls are duplicated, the possible implications could be explored. A compound profile could
be created to narrow down potential substrate acceptors of PGT 4.
Further screening with representatives from other flavonoid subclasseses not previously
tested could be conducted to find PGT 4’s preferred substrate acceptor. Although PGT 4 did not
exhibit any flavonoid glucosyltransferase activity with tested flavonoids, the enzyme could be
further tested to reveal activity with other secondary metabolites such as simple phenolic
compounds. Previous work has shown GT activity with some phenolic compounds using reverse
high performance liquid chromatography (Wamucho 2012, Hayford 2012).
If no glucosyltransferase activity is found, it may be necessary to use a yeast expression
vector that can cleave the fusion tag after purification to rule out any interference of the extra
sequence on the GT activity of the enzyme.
This work has helped to narrow down the list of possible substrate acceptors of PGT 4.
With this knowledge, further work, including the suggested methods, will elucidate the preferred
substrate of PGT 4 and help to distinguish its role in grapefruit metabolism.
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Buffer Recipes

50X TAE Buffer
•
•
•
•
•

50 mL EDTA (pH 8.0)
28.6 mL glacial acetic acid
121 grams Tris Base
Add dH2O to 1000 mL
Add 20 mL of 50X TAE to 980 mL dH2O to dilute to 1X TAE for agarose gels

1 M Potassium Phosphate Buffer, pH 6
•
•
•
•

132 mL 1 M K2HPO4
868 mL 1 M KH2PO4
Adjust pH to 6 with KOH if needed.
Autoclave for 20 minutes and store at room temp

Breaking Buffer , pH 7.4
•
•
•
•
•
•
•
•

6 grams monobasic sodium phosphate
372 mg EDTA
50 mL glycerol
Dilute to 900 mL
Adjust pH to 7.4 with NaOH
Dilute to 1 Liter
Store at 4oC
Add desired protease inhibitors
o 50 µL of 0.1 M PMSF was added to 5 mL BB before lysing cell pellets.

5X SDS-PAGE TANK Buffer
•
•
•
•
•

15.1 grams Tris base
94 grams glycine
Dilute to 900 mL with distilled water
Add 50 mL 10% SDS
Dilute to 1 Liter with distilled water

10X Western Blot Transfer Buffer
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•
•
•
•
•
•
•

30.3 grams Tris base
144.1 grams glycine
Dilute to 1 Liter
Store at 4oC
100 mL 10X stock
700 mL distilled water
200 mL methanol

5X Tris-Buffered Saline (TBS)
•
•
•
•
•
•

40 grams NaCl
1 gram KCl
15 grams Tris base
Dilute to 800 mL with distilled water
Adjust pH to 7.4 with HCl
Dilute to 1 Liter with distilled water

Alkaline phosphatase buffer
•
•
•
•
•
•

1.17 grams NaCl
203 mg MgCl2 – H2O
2.42 grams Tris
Dilute to 80 mL with distilled water
Adjust pH to 9.5 with HCl
Dilute to 200 mL with distilled water

Blocking Solution
•
•
•

2.5 grams milk powder
40 µL sodium azide
Dilute to 50 mL with 1X TBS

Developing Solution
•
•
•
•

45 mL alkaline phosphatase buffer
Add following immediately before developing Western blots
180 µL NBT in 0.083 g/mL in 70% N,N-dimethylformamide
180 µL BCPIP in 0.42 g/mL in 100% N,N-dimethylformamide

50 mM Phosphate Buffer (pH 7.5)
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•
•
•
•
•

0.2918 grams monosodium phosphate
0.7733 grams disodium phosphate
Add 900 mL distilled water
Adjust pH to 7.5
Dilute to 1 Liter

Column Buffer (pH 7.5)
•
•
•
•
•
•

0.2918 grams monosodium phosphate
0.7733 grams disodium phosphate
17.532 grams NaCl
Add 900 mL distilled water
Adjust pH to 7.5
Dilute to 1 Liter

IMAC Elution Buffer (pH 7.5)
•
•
•
•
•
•
•

0.2918 grams monosodium phosphate
0.7733 grams disodium phosphate
17.532 grams NaCl
10.21 grams imidazole
Add 900 mL distilled water
Adjust pH to 7.5
Dilute to 1 Liter

IMAC MES Buffer (pH 5)
•
•
•
•

3.9046 grams 2-(N-morpholine)-methanesulfonic acid (MES)
Add 900 mL distilled water
Adjust pH to 5
Dilute to 1 Liter
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Media and Stock Solution Recipes
Low Salt LB Media
•
•
•
•
•
•
•
•
•
•

10 grams tryptone
5 grams yeast extract
5 grams sodium chloride
Add 450 mL dH2O and stir with magnetic stirrer
Adjust pH to 7.5 using 6M NaOH
Fill up to 500 mL with dH2O
Autoclave for 20 minutes
Cool to room temperature
Store at 4 oC
Add antibiotic as necessary
o Ampicillin – 100mg/L
o Zeocin -25mg/L

LB Agar Plates
•
•
•
•
•
•
•
•
•

Low Salt LB media
Agar ( 15 grams/L)
Add agar to desired amount of Low Salt LB media and autoclave for 20 minutes
Cool at 42oC
Add desired antibiotic (see above concentrations)
Pour into sterile plates
Allow to harden and cool.
Store inverted at 4oC
Cover LB Zeocin plates with aluminum foil

Phenol:Chloroform Solvent
•
•
•
•
•
•
•

Combine equal parts of phenol and 0.5 M Tris-HCl, pH 8
Add 0.1% 8-hydroxyquinoline 2-carboxylic acid
Stir mixture for 15 minutes.
Remove upper layer of the mixture
Add an equal volume of 0.1 M Tris-HCl to the mixture
Stir for 15 minutes
Repeat above steps until pH of phenol: chloroform is above 7.8

10 X YNB (pH 5.4)
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•
•
•
•
•
•
•

134 grams of yeast nitrogen base (YNB)
100 grams ammonium sulfate
Add 900 mL distilled water
Adjust pH to 5.4
Dilute to 1000 mL with distilled water
Heat solution to dissolve completely
Filter sterilize and store solution at 4oC

500 X B (0.02% Biotin)
•
•
•

20 milligrams biotin
Dilute to 100 mL with distilled water
Filter sterilize and store solution at 4oC

10 X D (20% Dextrose)
•
•
•

200 grams of D-glucose
Dilute to 1000 mL distilled water
Filter sterilize and store at room temp

10 X M (5% Methanol)
•
•
•

5 mL methanol
Add 95 mL distilled water
Filter sterilize and store at 4oC

10 X GY (10% Glycerol)
•
•
•

100 mL glycerol
Dilute to 1000 mL with distilled water
Filter sterilize and store at room temperature

YPD Liquid Media
•
•
•
•
•
•

10 grams yeast extract
20 grams peptone
Dilute to 900 mL with distilled water
Adjust pH to 7.5 using 6M NaOH
Autoclave for 20 minutes
Add 100 mL 10 X D

YPD Agar Plates
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•
•
•
•
•

Desired amount of liquid YPD media
Add 15 grams agar/ liter
Autoclave for twenty minutes
Add antibiotic, Zeocin (100 mg/L)
Store in dark at 4oC

YPDS Media and Plates
•
•
•
•
•
•
•
•
•
•
•

10 grams yeast extract
20 grams peptone
182 grams sorbitol
Dilute to 900 mL distilled water
Adjust pH to 7.5 using 6M NaOH
For plates, 15 grams agar / liter
Autoclave for 20 minutes
Add 100 mL 10 X D
Cool solution to 42oC in water bath
Add antibiotic, Zeocin (100 mg/L)
Store plates in dark at 4oC

BMGY / BMMY Media
•
•
•
•
•
•

•

10 grams yeast extract
20 grams peptone
Dilute to 700 mL with distilled water
Adjust pH to 7.5 using 6M NaOH
Autoclave for 20 minutes
Cool to room temp and add:
- 100 mL sterile 1M potassium phosphate buffer, pH 6
- 100 mL sterile 10 X YNB
- 2 mL sterile 500 X B
- 100 mL sterile 10 X GY for BMGY
- 100 mL sterile 10 X M for BMMY
o
Store at 4 C

2X PCR Master Mix
•
•
•
•

200 µL 5X GoTaq Reaction Buffer
2 µL 100 mM dNTP Mix
5 µL GoTaq enzyme of 5 u/ µL stock
Add sterile, distilled water to 500 µL

Coomassie Blue staining solution
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•
•
•
•

6 mg Coomassie Brilliant Blue G250
10 mL acetic acid
40 mL methanol
Dilute to 100 mL with distilled water

Destaining solution
•
•
•

300 mL 30% methanol
100 mL 10% acetic acid
Dilute to 1 L with distilled water
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APPENDIX C
Gel Recipes

0.8% Agarose Gel
•
•
•
•
•

0.24 grams of agarose
Add 30 mL 1X TAE (pH 8.2)
Heat for 1 minute in microwave
Add dH2O to fill back up to 30 mL
Add 2.5 μL of EtBr (10mg/mL)

SDS-PAGE

Distilled water
40% Acrylamide and
bis-acrylamide solution, (19:1)
1.5 M Tris, pH 8.8
1.0M Tris, pH 6.8
10% SDS
TEMED*
10% APS
* add last
Total

10 % Separating Gel
2.3 mL
1.3 mL

5 % Stacking Gel
1.5 mL
260 μL

1.3 mL
-------50 μL
2 μL
50 μL
5 mL

-------250 μL
20 μL
2 μL
20 μL
2 mL
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